EP0800680A4 - Systeme de gestion des prescriptions - Google Patents

Systeme de gestion des prescriptions

Info

Publication number
EP0800680A4
EP0800680A4 EP95937691A EP95937691A EP0800680A4 EP 0800680 A4 EP0800680 A4 EP 0800680A4 EP 95937691 A EP95937691 A EP 95937691A EP 95937691 A EP95937691 A EP 95937691A EP 0800680 A4 EP0800680 A4 EP 0800680A4
Authority
EP
European Patent Office
Prior art keywords
drug
patient
prescription
data
management system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95937691A
Other languages
German (de)
English (en)
Other versions
EP0800680A1 (fr
Inventor
Christian Mayaud
Jonathan Edelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Health Med E Systems Corp
Original Assignee
Advanced Health Med E Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/330,939 external-priority patent/US5737539A/en
Application filed by Advanced Health Med E Systems Corp filed Critical Advanced Health Med E Systems Corp
Publication of EP0800680A1 publication Critical patent/EP0800680A1/fr
Publication of EP0800680A4 publication Critical patent/EP0800680A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers

Definitions

  • This invention relates to professional data management systems useful in the production of product specification documents such as prescriptions, service or parts orders, insurance contracts and the like that require detailed product and history information from multiple extensive information sources, especially remote heterogenous sources. More particularly, the invention relates to systems that assist professionals perform their everyday work in " specifying customized technical products. A particularly preferred embodiment relates to a computer-implemented prescription management svstem to assist physicians in prescribing and reviewing drugs. BACKGROUND
  • information regarding relevant new drugs, comparative efficacy, and importantly, relative costs may not be readily and conveniently available to a physician creating a new prescription, as well as relevant patient information such as current conditions being treated, current treatments, and preferred medications for conditions, pursuant to requirements of the patient's drug formulary.
  • Unwitting failure by a prescriber to follow formulary guidelines can impose unnecessary or unexpected cost burdens on the patient, or their benefits provider, and lead to poor patient compliance and aggravating and time-consuming disputes.
  • the cost in dollars of non-compliance with drug formulary guidelines to benefit-providing corporations, insurers, health maintenance organizations and government providers, for example MEDICAID and MEDICARE, can be enormous.
  • the cost of poor patient compliance may ultimately increase the total cost of care by generating a more serious, expensive adverse health outcome ( emergency room visit, or hospital admission or death).
  • a difficulty in making integrated patient-specific information readily available to prescribing professionals is that the needed information components are not centralized but are widely distributed geographically and even when their geographic or electronic locations are known, are hard to access because of proprietary and liability and patient-confidentiality concerns and because of system, file or protocol incompatibilities.
  • prescription writing is generally a manual process. After consulting with a patient to determine their problems and diagnosing, or attempting to diagnose their condition or disease, a physician selects a drug and a dosage and an amount to prescribe based upon their own personal knowledge and experience, if necessary using available reference materials which may or may not include promotional materials from drug manufacturers. A prescription is then written up under the physician's signature and bears a patient identification, a drug name, dosage amount and timing, refillability information and the physician's signature, the date, possibly an advisory regarding contraindications, and little other information. While a prescription may be typed, keyed or otherwise "generated" on a computer most prescriptions are still manually written.
  • Prescribing activity should be a good field for computerization, but one difficulty is the lack of apparent benefits to many physicians. Paper prescription pads are small and easily carried around by a physician. Manuallv writing a prescription will often be quicker and easier than using a computer, however good the system. The benefits of automated information systems often come not from greater data entry efficiency, but from the increased efficiency of the entire process, from the value of the transaction records generated and also from the control of the transaction entry process which may ensue. Phvsicians who are not computer-literate or who are even "computer-phobic" will require a most compelling reason to adopt a computerized prescription management system.
  • a prescription management system must be readily usable by a wide range of physicians, preferably for all their prescribing activity must provide compelling value to patient care and increase overall treatment management efficiency. Providing an attractive computer-based system to physicians is fraught with unexpected difficulties.
  • Physicians and other health care professionals are representative of certain groups of professionals whose unique characteristics raise obstacles to the computerization of their day-to-day professional activities.
  • a computerized professional management system should be capable of flexible integration into their personalized and varied work flows.
  • Portable computers are a possible solution to the access problem now that powerful and compact notebook computers are widely available. Although currently available portable computers offer some advantages particularly to physicians moving between one work place and another, they also suffer certain drawbacks.
  • One drawback is that external communication is difficult being commonly effected by moving diskettes, a valuable but limited method, or by modem connection to a telephone line which inconveniently requires plugging into a wall jack. Though possibly adequate for a physician having multiple offices, neither the communication means nor the portability of such systems is satisfactory for a ward physician moving from patient bed to patient bed.
  • the weights and form factors of traditional portable computers are severe impediments to their assimilation into many clinical physicians daily lives as dependable assistants to their professional work.
  • a broad objective of this invention is to provide a prescription management system that can be used by physicians on such mobile computing devices.
  • a further object of this invention is to provide a prescription management system which personalizes itself to the prescribing patterns of experienced users.
  • This invention solves a problem. It solves the problem of providing a computerized, prescription management system that an average prescribing physician can use and will want to use and which makes possible significant improvements in the quality of prescriptions written. In preferred embodiments, the invention also solves the problem of significantly reducing prescription costs to patients and to their drugs benefit management company or government agency.
  • the invention solves these problems for physicians by providing a prescription management system for electronic prescription creation by a prescriber at a point of patient care, said prescription being usable by a pharmacist to dispense drugs, said prescription management system comprising: a) electronic posting means to select and capture in said prescription: i) a patient identifier; ii) a prescribed drug; iii) a dosage for said prescribed drug; and b) a patient-condition treatment specification procedure; whereby in creating said prescription said prescriber specifies a patient condition for treatment by said prescribed drug.
  • the invention provides a computer-based professional product specification system for use by other professionals, in addition to physicians, which can deliver substantial benefits to mobile, users who may be computer-inexperienced.
  • a treatment objective is both expressed and recorded,... physician intent... and deliver for physicians the problem is solved by providing a user- friendly prescription management system, requiring minimal data entry enabling prescriptions to be created with an overall efficiency unobtainable by any known automated system and which can helpfully supplement the skills of the best of practitioners.
  • the drugs in the drug list are classified according to a patient condition for which the drugs are effective and the onscreen drug selection procedure lists multiple drugs for treating each patient problem.
  • the user makes a drug selection by generic or brand name or some other drug identifier, and the system supplies, suggests or requires, entry of an appropriate treatment condition so that the patient record is completed with the condition or conditions for which the selected drug is prescribed.
  • the invention also provides a user-adaptive prescription management system for electronic prescription creation by a prescriber at a point of patient care, said prescription being usable by a pharmacist to dispense drugs, said prescription management system comprising: a) electronic posting means to select and capture in said prescription: i) a patient identifier; ii) a prescribed drug; iii) a dosage for said prescribed drug; b) a patient-condition treatment specification procedure whereby in creating said prescription said prescriber specifies a patient condition for treatment by said prescribed drug; c) an onscreen drug selection procedure having a patient condition list specifying multiple possible patient conditions, having a drug list specifying multiple possible prescribable drugs and having drug specification means to select and post a desired drug to said prescription; and d) tracking means to track preferred data usage by a user and to adapt data displays to favor such preferred usage, whereby the system learns and adapts to a user's habits; wherein drugs in said drug list are classified according to a patient condition for which said drugs have efficacy and said onscreen drug
  • Drug lists or individual drug selections or suggestions may be presented to prescriber- users in any of a variety of ways for example by frequency of prescription for a selected condition, based upon either the user's historical prescription activity or a wider base of historical prescribing activity, which could be nationally or regionally defined or derived from a drugs benefit house, health maintenance organization, hospital or other appropriate institution.
  • ystem suggestions for condition-related drug selection may be further refined into categories such as relative cost, generic or brand name and so on. Where many drugs are available for treating a patient's active condition, one particularly useful presentation is by multiple lines of therapeutic preference according to drug formulary guidelines. Thus, within the patient's particular formulary there may be suggested first, second and third lines of therapy. Different suggestions may be made for different patients according to the preferences of the patient's particular drugs benefit management company.
  • the system includes a comprehensive database of approved drugs classified by conditions for which they are known to have therapeutic effect and this database need not be maintained in the users station but should be accessible in real time to the user.
  • Many valuable professional benefits are obtained by delivering a selective listing of drugs by condition to a physician. For example in treating a particular chronic condition such as gastro-intestinal disease, a physician may find that common medicaments such as antacids are ineffective, that a particular brand name drug such as TAGAMET (trademark) has, with prolonged use, undesired side effects so that the physician may at this point be interested in gaining information about alternative drugs with which they are less familiar.
  • TAGAMET trademark
  • the physician does not have the information at their finger tips, this could be a time consuming process in their office reviewing files and other archival information systems they have.
  • Alternatively on ⁇ line electronic services may be used but this can also be a time consuming process.
  • the preferred embodiments include back-up prescribing information on each drug, along with details of literature references supporting its manufacturer's therapeutic claims or with means enabling the physician promptlv to obtain such references.
  • the invention is not limited to providing a prescription management system. It can provide, in the medical field alone, systems for clinical laboratory management, for medical record management for radiology management and the like. In addition the invention can provide novel professional data management systems that can create new products and yield comparable benefits in other professional spheres where professionals are responsible for specifying more or less complex technical products to solve client or customer problems.
  • the invention provides a professional product specification system for electronically creating a technical specification usable by a professional to specify technical products said product specification system comprising: a) electronic posting means to select and capture in said technical specification: i) a customer identifier; ii) a specified product; and b) an onscreen product selection procedure having a product benefit list specifying multiple possible customer benefits having a product list specifying multiple possible specifiable products and having product specification means to select and post a desired product to said specification; wherein products in said product list are classified according to a customer benefit which said products can provide and sai onscreen product selection procedure lists multiple products for providing each said customer benefit.
  • Figure 1 shows a system entry screen of a prescription management system embodiment of the invention which system incorporates the screens of Figures 2- 1 1 ;
  • Figure 2 is a patient selection screen
  • Figure 3 shows a prescription creation screen
  • Figure 4 is a condition list selection screen
  • Figure 5 is a condition selection screen
  • Figure 6 is a drug selection screen, condition specified
  • Figure 7 is a nonformularv drug selection screen
  • Figure 8 is an alternative condition-specification and drug selection screen
  • Figure 9 is an alternative direct drug specification screen
  • Figure 10 is a condition selection screen, drug specified
  • Figure 1 1 is a drug selection evaluation screen
  • Figure 12 is a single prescription history screen.
  • Figure 13 is a patient problem history information screen
  • Figure 14 is a manually updatable problem list maintenance screen;
  • Figure 15 illustrates a scheduled dosage drug package;
  • Figure 16 is a schematic diagram of one way of connecting users of the prescription management system of Figures 1 -14 with remote source databases across network to provide data and processing resources needed during operation of the prescription management system and useful inter alia for creation of a virtual patient record.
  • the prescription management system illustrated in Figures 1 - 14 can be provided in software for single-user operation on a stand-alone personal computer for use, for example, by a sole practitioner or for multi-user operation on a local area network for use, for example, by physicians and other prescribers within a single facility, hospital, group practice, or the like prescribing organization, and the invention can bring substantial benefits to such users and their patients.
  • a preferred embodiment of prescription management system comprises a host computer facility supporting wired or wireless network delivery of user-relevant components of said prescription management system to multiple remote user interface devices.
  • the host computer facility provides data, or access to data, data processing and communications resources for users to draw upon via the user interface devices.
  • the host computer facility can be a server or cluster of servers with associated data storage volumes, and at least one intelligent client providing access to the server or servers.
  • the host computer facility can call upon a variety of external resources and functions as a marshalling and processing center for organizing resources into useful and manageable pieces for utilization by limited capacity user-interface devices.
  • it is a co-ordination point on a network for a number of user- device clients.
  • the network accesses or includes a number of remote database sources providing useful information elements to the system.
  • the screens shown employ user-friendly data selection and data entry devices such as are familiar to many computer users in Apple Corporation's Macintosh® (trademark) and Microsoft Corporation's Windows operating systems, for example activatable buttons, pointers, scroll bars, icons, arrow key, drop-down menus, windows and other screen symbols designed for actuation by a pointing device, for example, a mouse or trackball. More preferably, for compact "pocket-book" computer applications, the pointing device is a pen or stylus.
  • the prescription management system shown in this embodiment of the invention has been designed for implementation on phvsicallv compact, portable, user-interface devices such as small portable personal computers, especially hand held devices known as personal digital assistants.
  • phvsicallv compact, portable, user-interface devices such as small portable personal computers, especially hand held devices known as personal digital assistants.
  • the system can readilv be used on or adapted to other hardware platforms, for example, a physician's desktop computer and can be expressed in different software interfaces from that shown, especially ones that use different input devices such as keyboards, touch pads or touch screens and the like.
  • the screens automatically personalize themselves, with use, to adopt the patterns and habits of a regular user of a particular device platform for the system, offering the user their most frequently used information, drugs, conditions, patients or patient groups, and so on as first line choices.
  • This adaptive characteristic is a valuable benefit endearing the system to experienced users who may become impatient with hierarchically accessed data.
  • Tlie data lists, categories, groups, addresses or routes can be organized in multiple hierarchies for rapid and flexible access to multiple large, remote databases, via multiple access routes to retrieve multiple related data elements and assemble them into a single data file, for example, a patient history file compiled from the data resources of a patient's historical health providers.
  • a desirable goal is to provide the physician-user with intelligent data lists that are, where possible, exhaustive and list, for example, all prescribable drugs, all conditions, all formularies or all patients and present the physician with helpful first-line choices or defaults selected intelligently on the basis of historical data known to the system.
  • the selection means is fully system embodied, or automatic, operating transparently to the user and requiring a minimum of configurational or setup operations by the user.
  • a virtual patient record can be created in a chronologically current version bv online interrogation of all possible primary sources of electronically recorded patient history elements, by retrieving those elements and assembling them into a complete record. Yet the record need neither be drawn from, nor committed to, permanent storage, obviating storage requirements for accumulations of patient records.
  • the record can be assembled dynamically, on an as-needed basis, consulted by an authorized system user, and then dissolved, without ever having been saved, giving the record a virtual character.
  • ecord element retrieval and record assembly are conducted under the auspices of the host computer facility employing a novel patient data directory service providing routing information to each patient's record elements.
  • the patient data directory service lists all institutions, including independent physicians, hospitals, HMO's, insurance companies, and so on, known to have source historical records on that patient, against a unique patient identifier, such as described hereinbelow. Also listed are routing or address data enabling the host facility to access institutional databases to retrieve record elements. Access protocols detailing, for example, what data can be accessed, when it may be accessed, by whom or by what organization or department it may be accessed, can be kept in a patient- specified directory, or elsewhere.
  • Patients not listed in the directory service can be searched at the remote source databases and, optionally, at other, host computer facilities supporting the inventive system for other groups of users.
  • This aspect of the invention avoids proliferation of a patient's confidential history and permits primary source data proprietors to act as exclusive wardens of their individual confidential data elements.
  • Bio-pattern recognition of personal user characteristics including, for example, handwriting, signatures, voice patterns and fingerprints is an attractive medium for accepting user inputs, but in the present state of development of the technology, suffers drawbacks which disfavor use of bio-pattern recognition in preferred embodiments of the invention. Future developments such as greater processing capabilities in small user-interface devices, and more accurate and efficient bio- pattern recognition techniques may change this picture and favor adoption of one or more forms of bio-pattem recognition.
  • handwriting recognition is eschewed in preferred embodiments of the invention, at the present time, because writing is more tiresome to the user than pointing, pressing or clicking and adds complexity and processing overhead to the system. Additionally, handwriting recognition, although presently available in pioneer systems, adds uncertainties, mav require significant user effort or adaptation and may threaten data accuracy or promote user error.
  • ignature recognition may be desirable, if permitted by regulatory agencies, for remote electronic authorization of fulfillment at the pharmacy especially for mail order prescription fulfillment and the pharmacy-prescriber link can, if desired, add additional levels of security by transmitting or exchanging supplemental electronic identifiers.
  • An aim of the invention is to provide a qualified prescribing professional with a valuable tool that imposes no significant burdens of weight or volume on the user, that demands little of their time and yet can respond rapidly, delivering valuable drug and patient information to the user from remotely located, disparate sources.
  • an aim of the invention is to provide an intelligent, knowledgeable computerized prescription pad.
  • Security ecuritv may be provided by password protection operating hierarchically on one or more levels, to provide varying degrees of access according to the user's level of authorization, as desired. Additional password or numeric code control may protect sensitive system-accessed information, for example, patient records, or parts thereof, or physician-user data, including personal lists and prescribing profiles.
  • Patient record access codes can, in selected instances, be patient provided, or granted by intelligent security control cards, having been furnished to the patient by a system administrator, or agent, prior to the physician encounter. Physician or other user access to a patient's record, or to sensitive details thereof, can thereby be restricted to a need-to-know basis. Access bv third parties to physician-related data can be similarly protected.
  • Provision for override of such security features should be available, for example for an emergency room doctor, and is allowed on a special case exception basis, is auditable, and traceable to the overriding user.
  • Password-controlled access to many computer networks is often workstation dependent with each workstation using a unique password to access the network.
  • user passwords may also be employed, these are often workstation- dependent, for example, being incorporated in the workstation's login scripts.
  • the present invention prefers that user access to the host computer facility be device- dependent so that a given user can access the system via any of numerous devices, provided they have the right password or passwords. By this means, users are not dependent upon a single device that may be lost or misplaced.
  • a still more preferred feature is to have user passwords which link each user with an individual profile or stvle sheet on the host computer facility representing the user's patterns of preferences so that the user-customization features of the system, which will be described more fully hereinafter, are readily available to the user independently of the particular interface device that happens to be employed for accessing the system.
  • a comprehensive drug database may be stored and maintained on such a host computer facility with selected data, for a particular drug list or an individual drug's formulation characteristics, being forwarded to the user's device on an as-needed basis, then being eliminated from the user device when no longer required.
  • Other activities mav advantageously be performed locally on the device, such as dynamic assembly of records from elements retrieved across the network from remote storage, and storage of the user's personal or most frequently referenced data and data lists, where the device's capabilities permit.
  • the user device is more powerful than present-day PDA's, for example a present-day desktop computer or perhaps the PDA's of the future, more processing and data storage functions can be retained at the user device rather than delegated to the network.
  • permanent (disk, diskette or flash memory) storage may have uses, security concerns can be better managed on the network than on the user device, so that it is preferred that minimal data be permanently stored on the user device. Accordingly physical storage resources of limited user devices are preferably allocated to AM rather than permanent storage.
  • a user profile can also be stored on the host computer facility so that if the user device is lost, broken or stolen, a new device can be automaticallv reconfigured across the network linking the user to the host facility, so that the application behaves the same.
  • such a host computer facility also provides customized services to each user device, performing "user-adaptive" functions for that device, as described herein, to adapt it to its authorized user or user's prescribing behavior and improve the level of assistance provided to the user.
  • a host computer facility also provides customized services to each user device, performing "user-adaptive" functions for that device, as described herein, to adapt it to its authorized user or user's prescribing behavior and improve the level of assistance provided to the user.
  • permanent storage capabilities of the device can be minimized in favor of faster AM storage capabilities.
  • the screens are designed to be non-intimidating to computer-inexperienced professionals and to present familiar information and terminology to them while avoiding specialist computer jargon. Individually, they are easy-to-use for novices yet rapid enough for experienced users. Collectively, they provide an appealing system interface which can flexibly integrate into a physician's personal work flow.
  • the screens are laid out in the manner of appealing logical forms that echo familiar data formats encountered by a physician in their day-to-day work.
  • An important objective is to make the screens self explanatory within the professional's normal terms of reference so as to avoid any need for access to help, although of course, HELP buttons can be provided if desired and extensive help documentation can also be provided, ystem utilities such as indexing, setup and purging are either concealed from the user or removed for execution on a remote host computer facility.
  • Data integrity and availability responsibilities are also delegated to the host computer facility, or its remote data suppliers. Thus data saving, archival, backup and data- replication functions are host facility responsibilities, not concerns of the user.
  • the system is designed to require a minimum of actual text or data entry, o far as possible, item entry is effected bv selection from lists of items, for example by highlighting an item, then clicking a mouse, or more preferably penning, to activate an item.
  • the prescription management system is made as user-friendly to physicians as possible, for example, by using familiar professional terminology and abbreviations. Thus terms such as “Patient” or “Pt”, “Drug” or “Rx”, “Condition” or “Dx” and “Treatment” or “Tx” are used rather than confusing generalities such as “subject” and "item” that often appear in generic software.
  • the Prescription Management ystem shown in this embodiment of the invention has been designed for use with small portable personal computers, especially hand held devices known as personal digital assistants. Those skilled in the art will understand that the system can readily be used on or adapted to other hardware platforms, for example, a physician's desk top computer and can be expressed in different software interfaces from that shown.
  • the svstem entry screen illustrated has a user-customizable button bar 10 which has been set with a conventional Quit button 12 and a Help button 14, along with a Mail button 1 6 for accessing an electronic mail ("E-Mail") system, a Prescribing button 1 8 for accessing the prescription management system embodiment of the invention, an Encounter button 20 for accessing a patient encounter management system (not further described herein).
  • Ans Svc button 22 accesses an answering service screen (not shown), which as a convenience function can be dynamically linked via the host computer facility to log incoming calls for the user.
  • the answering service is preferably intelligent and prioritizes, by flagging or displaying, patient- or treatment-related calls, for example those from a pharmacy, while screening out or de-prioritizes less relevant calls.
  • a Doctor's Lists button 24 accesses a more or less complex display of patient condition and therapeutic drug lists.
  • the drug and condition lists are linked together to associate a drug with one or more conditions for which it might be prescribed and, in most cases to provide the physician user with a conveniently displayed, concise selection of drugs for treating any particular condition.
  • the system has a user-adaptive character and adapts itself to the user's habits and prescribing patterns so as to service the user more efficiently.
  • the drug lists or the condition lists, or both are system-modified with use to reflect the prescribing frequency of particular drugs or the frequency of occurrence of particular conditions.
  • the inventive system is effectively cognizant of ongoing prescribing activity. It comes to know its user's environment and preferences, can adapt itself to any number of specialist situations, and can, if suitably equipped, subtly prompt the user, online with original, relevant, but elusive information derived from the user's computer-memorialized practice experience. For example the system may prompt the user that the last time Drug X was prescribed for Condition Y, Patient Q reported adverse reaction Z. Where the host computer facility documents a catalog of known adverse reactions to system-listed drugs, a system enhancement can report new adverse reactions to the user or centrally, to the host computer facility, by tracking logged patient conditions and relating them, where appropriate, to a previous prescription.
  • the system may log drug-drug interactions, which interactions can also be associated with a target condition or conditions.
  • Many other valuable retrospective statistical studies and analyses are made possible by deployment of the invention, as will be apparent to those skilled in the art. While such studies are potentially of immense public value if widely implemented, careful controls will be required to avoid reporting unrelated conditions as adverse drug reactions.
  • the user-adaptive prescription management system of the invention can be just as relevant and useful to, for example, a specialist in tropical medicine as it is to a pediatrician. This desirable result can be achieved without encumbering either specialist with the needs of the other.
  • the user's prescription management system can have built-in, online, statistical reporting functions enabling a physician user to review their, or others, historical experience with a particular drug or condition and providing online historical review of any other activities or data entrusted to the system.
  • the system is privy to and operates at the confluence of three powerful emergent data streams: encyclopedic data on therapeutic agents intended to moderate particular conditions or patient problems; data on individual prescriber activity using sldll and judgment to diagnose conditions or problems and make prescribing decisions selecting and applying therapeutic agents to diminish diagnosed conditions; and patient history data recording not only prescribing decisions but also the results of those decisions (see the description of Figure 12, below).
  • the system captures not only prescribing activity but also the prescribers intent, the problem or condition targeted by the prescriber in specifying a particular drug, and can track the success of that intent.
  • the linkage of treatment with condition treated captures the reason why the doctor took the prescribing action that was taken.
  • This intent may, and can legally, be different from approved FDA therapeutic indications for a drug.
  • the foregoing data may be aggregated for multiple users, for example by the host computing facility, for market research purposes.
  • an individual user's prescribing patterns may be reviewed by the user or by others.
  • drug benefits companies can review the user's prescribing patterns for formulary compliance and respond by encouraging better compliance, where appropriate, elease of such data to third parties can be controlled to safeguard the privacy of the prescriber, or other health care provider, by prescriber-determined data access protocols specifying who, or what organization, department or group, may access what data, when they may access it and what they can do with it. For example, one physician may permit academic use for research studies and prohibit commercial use while another may permit either.
  • buttons bar 10 can be made available from button bar 10 providing the user with user-configurable means to customize the system to their personal needs and tastes.
  • Intelligent drug-selection procedure keptical prescribers are encouraged to adopt the prescription management system of the invention, by its ability to bring to the point-of-care, in readily utilizable form, a battery of relevant drug-specification information and important patient-related information, much of which is not readily accessible at the point-of-care by conventional means.
  • Preferred embodiments of the invention achieve this desirable result by providing an intelligent drug-selection procedure which is supported by transparent connectivity to multiple remote proprietary information systems at the point of care, enabling a physician to draw upon the following categories of data: i) physician-user prescribing-frequency data; ii) patient drug formulary information as to a drug's status with a patient's drug benefits provider; iii) drug dosage characteristics, for example, form, size, route of administration, amount, frequency and the like; iv) drug-specific treatment information as to condition-related efficacy, and preferably as to contraindications and adverse reactions; v) relevant patient history information as to current and previous prescriptions, and preferably also, pursuant to the teaching of the present invention, problem-history information; and vi) laboratory and other diagnostic test information related to the patient's indications, to dosing, to therapeutic choices or to specific drug selections.
  • this data is brought to the point-of-care by relying upon retrieval from remote source databases at remote facilities responsible for capturing original update data, and not by relying upon redundant non-source data requiring constant synchronization with source data to remain current.
  • Diagnostic tests Items i)-v) above will be described in considerable detail hereinafter.
  • the invention contemplates electronically bringing relevant information to the point of care to assist health care providers make informed decisions, uch diagnostic information may comprise recommendations for clarifying a tentative diagnosis, or choice of diagnoses, or may comprise diagnostic results that can be used to make more informed therapy decisions and, in particular, to make better therapeutic drug selections.
  • Body system function tests for example renal or liver function tests are clearly valuable to a drug selection process, since renal and liver condition are important in determining dosages of some medications.
  • Other therapy-relevant diagnostic determinations can usefully be presented at the point of care, by means of the present invention, for example, drug-level determinations can enhance dosing decisions.
  • a useful, prescription management system-compatible patient encounter program can begin with a patient selection screen such as that of Figure 2.
  • the patient selection screen of Figure 2 can be activated by any one of multiple programs which may, for example, be initiated via the system entry screen of Figure 1 , but could be independent, free-standing programs or any other program for which the ability to create, update and modify a patient-specific record or a patient history is valuable.
  • Preferred embodiments of software procedures (or programs) associated with the novel patient record selection procedure illustrated in Figure 2 can access multiple remote databases to retrieve patient records, for example, by using the host computer facility, and can also post new patient records, and updates, created locally by the physician-user, to the multiple remote databases in real time, or in batch mode.
  • Patient record source data ource data for a typical patient record may be distributed across multiple, geographically dispersed, electronically incompatible, remote databases maintained for example by drug benefit companies, insurers, laboratories, medical facilities, diagnostic testing facilities and health maintenance organizations, including government agencies (MEDICAID, MEDICA E, etc.) and health care providers themselves, that have serviced the patient in the past.
  • MEDICAID government agencies
  • MEDICA E health care providers themselves, that have serviced the patient in the past.
  • Known automated patient record systems either ignore such remote data and work only with data created at the maintaining facility or vertically integrated health care organization, or create and maintain duplicates of the remote data.
  • the invention also provides novel data-retrieval network systems to retrieve relevant patient data elements from multiple remote heterogenous primary source databases.
  • relevant data elements for that record, or a record component (e.g. the most recent six-month or twelve-month portion)
  • record assembly which does not require undue hardware resources, can be performed on board the user device.
  • the record is viewed and may be printed out by the user, with patient authorization, but does not need to be permanently stored.
  • the host computer facility responsible for dynamic assembly of the virtual record logs the time, date and calling user to provide an audit trail of access to the patient's record, but does not commit the record to permanent storage. After use, the virtual patient record disappears, although it can be reconstructed archivally.
  • the record is required again, it is assembled anew, thereby incorporating any updates that may have occurred in the interim, for example changes in drug benefit status, insurance coverage or the like, newly generated laboratory, radiology or other diagnostic results, or other, e.g. emergency, prescriptions dispensed.
  • the act of assembling a record externally of its sources immediately dates the record: it is cut off from any updates, and therefore liable to become incomplete, obsolete or dated.
  • Virtual patient record assembly as described herein, avoids this problem making local storage of patient records unnecessary.
  • Transactions are archived by the host system to provide a complete transaction history, so that past activity can be reconstructed, uch a data-reconstruction capability to provide clear hind vision of the patient's record at any given time is an •Zo- important medicolegal capability.
  • That historical version is preferably reconstructed from a transaction log and assembly of timed and dated record elements, or segments, in a manner not unlike that used by version control software.
  • Creating a virtual patient record permits optimal data currency and accuracy and, by avoiding unnecessary redundant copies of patient data minimizes liability for misuse or unauthorized access.
  • Patient confidentiality can be maximized and is verifiable by the system-generated audit trail.
  • each record element is required to be at least dated and preferably also to be timed at source, such timing and dating relating to whatever event created the record.
  • chronological data is useful for retrospective archival reconstruction of a record as it existed (in its elements) at any given point in time. This can be achieved by retrieving record elements, as described above, using a suitable date filter and if appropriate, a time filter, to include only those (or selected ones of those) record elements that existed at the desired given point in time.
  • source database proprietors can remain wardens of the only copy of that data and obtain patient authorization to be the sole repository of that data.
  • Laboratories can keep laboratory records; insurance companies can keep insurance records; hospitals can keep hospital records; and health maintenance organizations can keep their own records; without ever having to release copies of these records into external electronic storage by third parties, with the security hazards attendant upon such releases. Any electronic release made externally using the data access control features described herein can be assured of always being authorized by whatever entity, be they patient, physician or organization, that has proprietary rights in the data.
  • a patient selection screen for example as shown in Figure 2 is displayed as a preliminary to prescription management functions, eferring to the patient selection screen of Figure 2, the name, age, gender, and social security numbers of patients who have authorized the user physician to treat them, or to access the system on their behalf, are listed under respective column header buttons, namely, Name button 26, Age button 28, Gender button 30 and Social Security # button 32.
  • Lists can be scanned, or text entries made in a blank search box 34 at the top of the screen, using string or full name searches to locate the desired patient or to review the patient list.
  • Column headers 26-32 can be clicked or touched to sort the patient list on any of those fields and activate search box 34.
  • earch box 34 is linked to the sort fields so that, for example, if the listing is sorted by social security number then alphabetical entry attempts are rejected from search box 34 and numeric entries are used as social security number locators.
  • the characters can be keyed or system provided from pop-up screens, or voice or handwriting recognition may be employed.
  • New Pt button 36 activates a new patient entry bar, while the Ok button 39 accepts a highlighted patient selection and advances to the prescription management screen of Figure 3.
  • Cancel button 38 returns to the system entry screen of Figure 1.
  • preliminary selection of groups of patients can be made by providing various patient lists, for example "Today's Patients”, “In-Patients”, “Out-Patients”, “Private Patients” and the like, uch patient lists are preferably system-maintained, on an ongoing basis, using the latest data available to the system and preferably enable the user to select a convenient group of patients that has a high probability of including the next patient or patients to be encountered, thereby speeding access and retrieval of a desired patient record.
  • such grouping of patient records into lists also facilitates organization by a host computer facility of display data into small batches that can more rapidly be communicated via limited capacity copper wires and modems and are of a size that can conveniently be held in AM on a small, portable user device.
  • the invention provides careful controls to alleviate such fears and to prevent unauthorized access to a patient's data or to their physician's prescribing profiles.
  • the system provides data access controls such that the only accesses that can occur are those that have been authorized or preauthorized, at a point of care or elsewhere, in accordance with security profiles on the network established on behalf of data-proprietor entities such as patients, physicians or organizations. It is further preferred that the entity's security profile, or filter, details what data can be accessed, when it may be accessed, where it may be accessed and by whom it may be accessed.
  • numeric or alphanumeric user identification codes provide some level of security, higher levels are provided bv using graphic, photographic or fingerprint recognition to identify a system user.
  • More preferred embodiments of the invention can ensure a still higher level of confidentiality by automatically maintaining a complete audit trail of access to patient data.
  • the audit trail details, for every access, who or what organization accessed the record, what part of the record was accessed, when it was accessed (both date and time) and what was the purpose of viewing the record.
  • associated with every patient record is a timed and dated log of every physician user, organization or health care professional accessing that record. If desired, the log can be reported, or made available to a patient, on request, for example through online access (with careful security controls), via print or fax, and so on.
  • Patient-directed control of the flow of their own data can be achieved by centrally inputting at the, or a, host computer facility patient-generated record-access specifications to determine which users, or user organizations or departments (for example clinics), can access what data during what period and what uses can be made of the data.
  • patient-generated record-access specifications must not deleteriouslv restrict physicians in the execution of their - z- professional missions, uch record-access specifications or profiles could be maintained at a remote database rather than the host computer facility.
  • access to their records is controlled by patients and individuals and organizations can be given patient-defined, selective access or access based on a need to know, or a patient may block access to all data flow, if they wish.
  • physicians may be able to override a patient security block, but such events are recorded so that any abuse can be monitored and action can be taken to discourage abusers.
  • vstem resources may be used to compile any desired historical record of a user's prescribing activities.
  • Patient-confidentiality aspects of this data have been addressed above and can be satisfactorily managed by controlling access to patient-related data in accordance with a patient's previously, or currently expressed wishes, as described herein.
  • the historical record may be rendered patient-anonymous by stripping the data of recognizable patient identifiers, or aggregating the data.
  • the resultant historical prescribing data can communicate significant information about the prescriber, is personal and proprietary to the prescriber.
  • the prescriber's rights in their historical prescribing data are protectable in a manner similar to the protection affordable to patients, by providing prescriber-determined access control specifications detailing permissible levels of third-party access to prescriber data, uch prescriber data access control specifications can be stored in individual files on the network and can comprise as to who or what organization, or type of organization may access what data, for what purpose and for what period of time such access right may be effective. Clearly, multiple levels of access control may be described to any desired degree of complexity.
  • User preferences mav include user authorization for data access by various third parties for example health maintenance organizations (HMO's), hospitals, government agencies, managed care organizations and so on.
  • HMO's health maintenance organizations
  • a particular group to whom a prescriber may wish to yield access rights comprises collective bargaining associations, for example independent practitioner associations, preferred provider organizations and physician hospital organizations.
  • all accesses to a prescriber's data are system stamped with a date, time and accessor ID, to create an audit trail of such accesses, similar to the audit trail left by accesses to patient data.
  • ystem-determined access control can be invoked, whenever a prescriber data access request is received, by referencing the prescriber's access control file and permitting or denying access in accordance with the file's specifications.
  • prescription creation screen 39 has a full array of user- activatable buttons enabling a physician to draw on powerful resources within the prescription management system and supporting it in the host computer facility and associated data-retrieval network, as will shortly be described.
  • a patient features bar 40 Near the top of screen 39 is a patient features bar 40 below which a prescription features bar 42 coordinates all features necessary to review current therapy and order changes in treatment, or order new treatment, for the selected patient.
  • a prescription history zone 43 extends across the middle of the screen, the lower screen portion contains a prescribing zone 44, and a screen title 45 appears at the top of the screen.
  • Patient features bar 40 comprises a Select Patient button 46, a selected patient indicator 48, in this case Mary Harrington, a patient Problems button 50 and a patient Allergies button 52.
  • Beneath Problems button 50 are displayed Mary Harrington's currently active problems 51 or conditions, shown here as pharyngitis and bronchitis.
  • Beneath Allergies button 52 are displayed Mary Harrington's l ⁇ iown allergies. Pressing or otherwise activating Problems button 50 or Allergies button 52, opens a window or screen listing problems or allergies from which a physician, or other professional user, can select new problems or allergies to add to Mary Harrington's record, or delete ones that are no longer active.
  • system- provided problem or allergy libraries may be organized into multiple lists with button 50 or 52, respectively, opening a list selection box as a preliminary to displaying a selected problem or allergy list.
  • Problems or conditions 51 and allergies 53 are here displayed as a helpful notation for the prescriber and do not become prescription elements as a result of being selected for display in this part of the screen. However, selections made here are functional in that selected problems 5 1 (conditions) will become defaults or preferred choices in a subsequent condition specification procedure and the system will review any drugs prescribed for relevance to allergies 53.
  • Prescription features bar 42 comprises an Rx History button 54, an Rx Options button 56, an Updating indicator 58, an Rx Info button 60 and a Renew Rx button 62.
  • Prescription history zone 43 displays those historical prescription details that may be relevant to a current prescription and has a Condition field 64, a Drug field 66, a Size field 68 a Dosing field 70, a generic flag 72, an Expires field 74 and a Mine field 76, in which the various characteristics of patient Mary Harrington's previous prescriptions are listed.
  • Prescribing zone 44 comprises three active buttons, New Rx button 78, Send Rx button 80 and Close button 82, below which extends a prescribing header bar 84 which contains field identifiers for data entry of a full complement of prescription details.
  • Available prescription detail fields comprise a Condition field 86, a Drug field 88, a Generic field 90, a Form field 92, a Size field 94, a Route field 96, an Amt (Amount) field 98, a Refill field 100, a Dosing field 102 and an Expires field 104.
  • Patient history zone 43 Multiple lines of the selected patient's prescription history are listed in patient history zone 43 in the middle of the screen for convenient review by the physician- user, and possible renewal, with scrolling or paging of extensive histories.
  • individual lines may come from multiple remote sources, uch histories are preferably compiled by the host computer facility in response to a call from the user device (see the description of Figure 16).
  • Prescribing zone 44 lower down prescription creation screen 39, allows a physician user to select and prescribe drugs and dosages, for the selected patient, in this case Mary Harrington, and to transmit the created prescription externally across a data network to other interested and authorized parties for prescription fulfillment, patient record updating and the like.
  • Select Patient button 46 returns to the patient selection screen of Figure 2 for selecting a different patient from one or more lists.
  • Select Patient button 46 draws up a "Today's Patients" list or whichever patient list the user last selected from, or a default, user-selected patient list, and provides the options of selecting a new patient from alternative patient lists.
  • Problems button 50 brings up a patient problem history information screen such as that shown in Figure 12 (to be described) in which a historical record of the patient's individual symptoms and diagnoses is listed and to which new problem reports can be posted.
  • a patient problem history information screen such as that shown in Figure 12 (to be described) in which a historical record of the patient's individual symptoms and diagnoses is listed and to which new problem reports can be posted.
  • historical information is not editable but may be supplemented, for example by reporting the subsequent status of a problem as (still) active or inactive.
  • any such additions to the record are stamped with the identity of the reporting physician, providing valuable elements of a treatment decision-maldng audit trail.
  • the patient's drug-related allergies, or drug reactions are brought up in possibly editable form (screen not shown) by activating an Allergies button 48 and may be automatically system updated, if desired by adding newly reported drug reactions and allergies. Desired personal or drug records relevant to possible allergies of this patient may be summoned from the host computer facility, which may in turn call on the remote database data-retrieval network for records or record elements.
  • Rx History button 54 scrolls, drops down, or otherwise accesses any additional patient history lines beyond what will fit in prescription history zone 43 and may introduce vertical or horizontal scroll bars, or both, into zone 43, enabling the user to display any desired section of a patient's prescription history in zone 43 with the top line of the history highlighted. Any desired prior prescription line displayed in zone 43, can be highlighted by clicking or pressing on it.
  • a highlighted prior prescription can be automatically renewed by clicking or pushing an Renew Rx button 62.
  • prescription creation screen 39 opens with the most recent prescription highlighted for possible renewal.
  • Activating Renew Rx button 62 posts a highlighted prior prescription into prescribing zone 44 for automatic renewal, after editing, if desired, enewal of anv prior prescription can thus be effected in as few, as two user steps by pressing Renew Rx 62 to post a highlighted previous prescription to prescribing zone 44 and a single further action to complete a prescription from there.
  • buttons such as Renew and Send Last Prescription or Renew All Active Prescriptions can be added.
  • Pressing header buttons Condition 64, Drug 66, or Expires 74 causes the drug history display to be sorted bv the selected header enabling the prescription history to be evaluated according to a particular parameter. This feature is of particular value for patients with long and complex treatment histories.
  • An important novel feature of the inventive prescription management system is the ability to associate a specific patient condition with each drug prescribed. By capturing detailed information on every prescription the system automatically builds a novel patient medical record having new uses in evaluating individual patient treatment and in enabling powerful new, multi-center outcome studies for evaluating therapies in various populations of patients.
  • a complete patient record of all activity within a region can be built.
  • this is a virtual patient record dynamically assembled only from original source data, which, as described above, is maintained in component form at multiple distributed source databases, is retrieved therefrom across a data- retrieval network from which the source databases can be accessed, and is compiled or assembled into a single virtual or transient record that appears to the user as an integral system data resource.
  • Patient histories generated by the inventive system can show not only the drugs prescribed, but also the conditions for which they were prescribed, allergies, demographics, insurance coverage, treating health care providers, and so on.
  • Known medical management systems do not provide listings associating each prescribed drug with a patient condition or problem, as reported to, or diagnosed by their physician.
  • Careful review of a patient's record for relationships between amelioration of problems and prescription of particular drugs can provide important information about the efficacy of a drug for a particular problem in a given patient, eview of a physician's prescribing record, detailing the various drugs selected to treat the different conditions exhibited by the patients encountered in the physician's daily practice, can reveal valuable information about the physician's prescribing practices and the degree to which they follow formulary guidelines.
  • This information is clearly of value to the individual physician and can, if desired, be enhanced by including in the problem record a condition severity rating, enabling declines (or increases) in severity to be reported.
  • the resultant patient prescription history replete with dated information as to patient problems, what drugs were prescribed to treat those problems, what forms, rovites of administration and dosages were used and, by implication from the timing and nature of subsequent problems, what the outcome of that prescription was, provides a very attractive treatment evaluation tool to a physician, and a powerful inducement to any professionally conscientious physician to use the prescription management system of the invention.
  • Implementation of the invention is expected dramatically to reduce the overall cost of prescriptions and this saving has been estimated to be from 20 to 40 percent of total prescription costs, avings will accrue initially to the drug benefit management companies who reimburse the direct costs of most prescriptions, but can be expected eventually to be passed to corporations and consumers by way of lower drug benefit rates. uch savings realized on a national scale would amount to many billions of dollars and provide an avenue of reimbursement for system proprietors. In the early 1990's, the cost of prescription drug benefits is one of the fastest rising components of all health care costs.
  • Outcome studies produced by the system may have substantial value to various parties, and their sale can support system costs, as may formulary compliance savings.
  • drug efficacy data is of value to pharmaceutical companies, as is early warning data from reliable specialists regarding adverse reactions, ubject to confidentiality and other relevant controls, such data can be automatically compiled and readily supplied by system management, requiring only approval, not active participation by involved physician prescribers.
  • the system may facilitate clinical trials by identifying health care providers or prescribers who would be likely participants in trials, based upon their having frequently diagnosed relevant conditions, or specified relevant drugs, as shown by their historical prescribing profiles, or relevant patient histories, Menble patient pools can be identified similarly.
  • additional information required for collection can be obtained by flagging selected prescribers' profiles to trigger additional on-screen routines so that whenever a trial-related drug or condition is selected by the prescriber, they will be asked to supply necessary additional information. For example, whenever a prescriber participates in a trial relating to treatments for gastritis, the system can request information as to whether certain tests were performed, and what were the results of those tests. Thus, the test drug might be appropriate for, or be in trials relating to, gastritis testing positive to H. pylori, whereas a different drug would be indicated for H. pylori-negative gastritis.
  • the system can also provide, preferably from source databases, complete prescription drug disclosure requirements as set forth by the FDA, including full cautionary information, for example as is now set forth in the Physicians' Desk eference (Medical Economics) and Physician's Gen x (Denniston Publishing) knowledge of which by the prescriber may be necessary to avoid malpractice liability, and dissemination of which may limit a drug manufacturer's liability.
  • Efficient promulgation of drug disclosure information to system users is tantamount to publication, yet can be more current than any printed document, and may be accepted as an alternative to hard copy publication or supersede it.
  • the system provides a valuable means for government agencies and others to communicate important messages, such as drug warnings and alerts, quickly and directly to physician users.
  • Electronic mail accessed via Mail button 16 can be used for this purpose, and may include priority flags triggering screen alerts, but a much more powerful route for communicating warnings relating to particular drugs is to associate the alert with system information on the drug so that when a user calls up the drug in question, they receive the warning or alert, or other special message.
  • cost:benefit data can also readily be prepared in outcome studies when individual drug costs are factored into the data, and such cost:benefit data can, in some circumstances have very substantial dollar value to drug benefits management companies whose objectives are to maximize the quality of care while minimizing the cost of that care.
  • Pharmaceutical and managed care companies can gain marketing benefits from use of the system to introduce new drugs or new uses of old drugs to physicians, in a relevant manner, at a moment of peak interest.
  • Optional system enhancements may enable post-introduction market surveillance of new drugs to be conducted for adverse outcomes to the treatment of a specified condition or conditions. For example the system may monitor patients reporting new problems after having been prescribed the new drug in question, refer such new problems to the physician user to qualify them for medical relevance and then statistically compare a collection of similar reports with data on a pool of similarly treated patients for significance.
  • the system provides a vehicle data collecting relevant data; parameters and a means for analysis of that data; and a means for disseminating alerts and advisories regarding newly discovered problems.
  • vehicle is used for all three steps.
  • one specialist pioneering a new drug for a particular condition may provide an early warning of adverse reactions not identified in clinical trials in a manner not heretofore obtainable, because of the difficulty of coordinating prescription and diagnostic data.
  • this information can be of immense value to a physician when treating a patient, widening the physicians' choices beyond their own field of knowledge (by suggesting new drug information) and helping the physicians optimize the prescribing process.
  • Another advantage of the invention is that each physician user inherently and easily supplies critical enabling data for outcome studies as part of the prescribing process. No extra effort is required by the physician to make the data available for studies.
  • One potential difficulty in maldng such studies is the existence of legal barriers to aggregating patient data into studies without specific patient permission. While this might be obtained on a piecemeal basis or by the prescribing physician, a much better solution is provided by centrally maintaining patient directed patient-record- access specifications, as described above. The system can then include only those records of patients agreeable to becoming study participants in such outcome studies.
  • the historical drug-prescribed and condition-treated records obtainable by using the invention can provide a basis for condition-based treatment guidelines developed by drug formularies.
  • This novel data provides a new vehicle for outcome research for managed care, leading to new approaches to cost-effective prescription treatments.
  • Compilation of an extensive or national database of (patient-anonymous) records providing a statistical historical listing of drugs prescribed versus associated conditions for which they were prescribed would be in the public interest and of considerable value, so long as patient-confidentiality were maintained. Widespread adoption of the present invention can help achieve this desirable goal. It is relevant to note that FDA regulations only permit a drug to be promoted for approved, specific therapeutic purposes but physicians are professionally free to prescribe an approved drug for any condition for which they believe the drug to be effective or useful so that, failing specific point-of-care diagnostic information, no assumptions can be made as to the treatment objectives of any particular prescription.
  • Drug field 66 may be a generic name or a brand name.
  • the Size field 68 is the dosage size.
  • Dosing field 70 shows the dosing frequency.
  • the "G" flag 72 is for generic and is a simple yes/no indicator.
  • An Expires field 74 displays an expiration date system calculated from the prescription quantity (not shown), the size and the dosing rate and indicates the day on which the prescription will run out.
  • Update button 58 can be a simple blinking indicator alerting the user that their device is communicating with the host computer facility and actively processing a local update. To indicate additional time taken accessing remote databases, the message can change to " emote etrieval", if desired. Additionally, Update button 58 can activate various update options, selectable from a menu, if desired. For example, Update button 58 may offer a selection of different sources from which to update the patient's prescription history.
  • While a preferred objective of the invention is that the prescription management system obtain a comprehensive, nationwide update of any previous prescribing activity regarding this selected patient, considerations of system speed, system development or marketing considerations may make it desirable to offer patient prescription histories drawn from all prescribing activity in a more limited geographical region, for example, local or regional updates local network updates or capability to update from the physician's institutional or office practice information systems.
  • New Rx button 78 highlights the first available blank line in the lower portion of the prescription management screen for creation of a new prescription by a physician-user.
  • the user receives intelligent decision support from the system of the invention.
  • the system proffers the prescribing physician comprehensive relevant prescribing data to enable creation of a new prescription intelligently, in an informed, manner with routine look-up functions being fully automated so that professional time spent on routine chores is minimized or eliminated.
  • data entries available via both Condition button 86 and Drug button 88 are selectable from extensive lists, as will be described hereinafter.
  • the system provides the user through their interface device and a linked host computer facility, transparently connectivity to multiple remote proprietary databases for retrieving necessary data such as drug and condition lists.
  • Generic field 90 is merely a toggled flag while Expires field 104 is a system-calculated field.
  • the drug name may be keyed in or, preferably selected by highlighting and clicking from one or more intelligently maintained lists presented in drop-down menus to post it to the respective highlighted field under Drug header 88.
  • the user can select a condition from a condition list and make a drug selection appropriate to that condition from a drug selection screen such as those shown in Figures 4 through 1 1 as will shortly be described in more detail.
  • Generic flag 90 is a simple yes/no indicator which is linked to each drug selection to approve generic drug substitution for brand name drugs by the pharmacist, if such substitution is permitted by state regulation.
  • the Form, Size, Route and Amounts headers 92-98 are linked to the drug selected and bring system resources to bear to enable a prescriber rapidly to quantify the prescription with appropriate dosages that can be filled at a pharmacy, without undue difficulty.
  • Activating any one of the fields under headers 92-98 drops down a menu, which menus together offer a selection of all known formulations of the drug selected, as provided by the manufacturer, using comprehensive drug inventory data accessed via the host computer facility or its supporting data-retrieval networks.
  • the entry for Form field 92 may be selected from choices such as capsule, caplet, tablet, and liquid.
  • Size field 94 might be a selection of 50 mg, 100 mg, and 200 mg and the Route field 96 selections might be "PO" for per oral, by mouth, "P " per rectum, "IV” for intravenous, and so on.
  • the displays are related and intelligently selected to display relevant options. Thus, for example, if “PO” is selected as the route of administration, only PO dosage forms are displayed. On the other hand, if PO oral forms are selected, "PO" appears as the route of administration.
  • the Amt field 98 is the amount or quantity of drug to be dispensed in the prescription, for example 30, 50 or 100 capsules or 50, 55, or 100 ml of liquid.
  • Refill field 100 shows the number of times refilling is permitted and
  • Dosing field 102 has two columns, one being a numeric designation of a number of tablets, caplets or liquid dosages to be taken at any one time and the other being an alpha indication of the dosing frequency such as QD for daily.
  • the system can calculate or suggest effective dosages for a selected drug, or a narrow range of effective dosages, according to dosage-relevant patient characteristics, for example, height, weight, age, sex, pregnancy and the like, taking into account the physical formulations in which the drug is l ⁇ iown to be available. While these characteristics might be entered or selected from lists during the prescription quantification procedure, greater power is obtained by including them on the patient's record and having the system reference these characteristics each time a new drug is prescribed for that patient and make dosage recommendations according to the l ⁇ iown behavior of the selected drug as it applies to the current patient.
  • dosage-relevant patient characteristics for example, height, weight, age, sex, pregnancy and the like
  • Expires field 104 can be system-calculated field from the entries in Amount field 98 and Dosing field 102, to indicate the dav on which the last dose will be taken.
  • the physician- user can select, or enter, an expiration date in Expires field 104 for example to coincide with a desired duration of treatment, or next visit, the system can back- calculate refills or the amount dispensed.
  • Back-calculating prescription quantifiers is useful to coordinate multiple prescriptions to expire on the same day, for the patient's convenience and to reduce potential errors or abuses.
  • Another valuable application of an expiration-controlled prescription is to benefit plan managers, enabling the physician, where appropriate, readily to coordinate prescription amounts to preferred schedules and programs of drug benefit plan managers, for example a ninety-day plan, uch preferred schedules can be system-offered or defaulted, if desired.
  • means can be provided for the physician themselves to write or key in the appropriate dosage entries for a selected drug.
  • the Drug and Condition fields 88 and 86 are linked together to express the therapeutic objective of the user's prescribing decisions, or the prescribing intent of the prescription, as will be described in more detail with reference to Figures 4 through 1 1.
  • a preferred objective of the invention is to minimize need for keyed data entry, to minimize information look-up, or preferably to avoid all need for keying, by providing a comprehensive system interfacing with the user through easily operated data entry devices such as employed in pen-based computer devices.
  • the prescription management screen of Figure 3 is preferably supported by comprehensive, fully adequate, up-to-date databases of drug information that, in a particularly preferred embodiment of the invention, provide a physician user with substantially all available relevant prescribing information on drugs, especially on those drugs they write most frequently, which may be favored with preferential device storage on the user's interface device, for rapid retrieval, elevant prescribing information on other drugs, written less frequently, or not at all by that user is available on the network.
  • Send Rx button 80 is pressed to output the newly created electronic prescription in any desired form such as to print, to local or remote storage or to remote file transfer as an electronic prescription.
  • the electronic prescription can be transmitted across a network for fulfillment by any specified pharmacy, for example, the patient's preferred pharmacy or a pharmacy preferred by the patient's drug benefit company for the particular patient's locality.
  • Preferred routing options can be provided for the patient or the drug benefit plan, or both, and the system can default to appropriate options for the patient's benefit plan, outing may be more or less complex and may for example split say a one-month prescription to provide a bridge prescription giving the patient an immediate one- or two-week supply from a local pharmacy, and sending the balance of the prescription for fulfillment by a lower cost mail order house.
  • a Bridge Rx button (not shown) may be added to prescription creation screen 39 to perform such a prescription-splitting function.
  • One approach to enhancing patient compliance employs a novel dose-scheduling drug package that is readily adaptable to accommodating and scheduling single or multiple prescription dosages to help a patient take the right dose of the right drug at the right time, and will be described in detail hereinbelow.
  • Another approach is, to some extent, inherent in features of the prescription management system described herein.
  • multiple physicians accessed by a patient utilize the system described herein, with common online access to, and assembly of, a patient's prescription history record whereby that record provides a current record of new prescriptions
  • a common abuse can be controlled wherein a patient presents a problem or condition to more than one physician to obtain multiple prescriptions with a view to indulging in abusive ingestion or illicit resale.
  • This problem is especially prevalent with analgesics.
  • a physician, or perhaps pharmacist if the patient's prescription history is available to the pharmacist, sees a similar current prior prescription has been issued, they can refuse to duplicate it.
  • Bringing fulfillment information from the pharmacy to the point of care via the patient's record or other convenient reporting medium, with or without the intermediary of a drug benefit company linked as a remote source database, can provide not only a valuable prescription abuse monitoring parameter but can also be used to enhance compliance with the prescribed treatment, especially if coupled with an alerting system.
  • the system may alert a prescriber that the intended expiration date of a critical prescription has passed without the prescription having been filled.
  • the prescriber thus becomes aware that the patient has gone off the medication and can take steps to contact the patient and alert them to the dangers or problems that may arise.
  • routine alerts can be passed to administrative personnel associated with the prescribing health care provider, notifying them of any unfilled prescription after a prespecified period of say two weeks or a month, or prescription expiration, or a shorter period for more critical medications.
  • a particular benefit the system provides when a patient has multiple simultaneous prescriptions is an ability to print out a dosing schedule or better still, to generate a scheduled dosage multi-drug package from the electronic prescription, for example as shown in Figure 15. Because the system knows dosage, dosage frequency and the duration of all prescriptions, it can report out what pills should be taken at different times of the day to comply with the requirements of multiple medications. The information used for such a further report can drive the dispensing of the drugs of a multi-drug prescription into a novel package which has multiple labeled or coded compartments for each of a number of dosing intervals.
  • Figure 15 shows a scheduled dosage drug pack 182 configured as a daily pack with the day of the week prominent and the date, patient and doctor identified.
  • Across pack 182 run three multi-compartment drug bays 184 each of which can accommodate up to four different solid drug formulations 184, pills, capsules, tablets, caplets, or the like and is sealed by a tear strip having an opening tab 186.
  • Each bay is clearly labeled with a time of day at which the dosage in each bay 184 should be taken.
  • Vertical zones 188 are dedicated to an individual drug and comprise a header with a drug name and special instructions (take with water, after food, and so on) and a compartment in each bay 184 for each dosage time.
  • a first drug is shown schematically in lefthand zone 188 with thrice-daily dosing, a second in left central zone 188 with twice-daily dosing and a third in right central zone 188 with once-a-day dosing, ighthand zone 188 is not used, but could be occupied by a fourth drug, the individual dosages of which are loaded into those individual compartments of ighthand zone 188 that correspond with desired dosage times or intervals.
  • modified drug packs 182 embodying the principles of that shown in Figure 15 could be configured for more (or fewer) doses or drugs or for different calendar periods, for example weekly or monthly packs rather than daily.
  • a multi-drug container could be in strip or roll or book form, or metal foil sheets, with tear or press-out compartments.
  • Dosing errors are common with patients with multiple prescriptions, especially the elderly. There can for example be difficulty in knowing whether a dose has been taken or not.
  • Drug pack 182 solves these problems in a simple inexpensive manner that is prescription controlled to organize multiple doses correctly and can be easily followed by most patients. Individual sealing of doses is hygienic and child- or overdose-resistant. Daily or weekly cards could be connected together by hinges to make compact concertina or book-like packs supplying a week or a month's prescribed drug requirements.
  • a scheduled dosage package could be standardized as to the number of dosage compartments, providing for example, a compartment for every hour, with those compartments lying between desired dosage times being obviously blank or never filled.
  • a valuable feature of such packaging which could be embodied in a single prescription package, is that by giving the physician-prescriber some physical control over the circumstances that exist when a patient is supplied with drug therapy for remote administration, the prescriber gains the freedom to adopt time-related dosage variations during the course of therapy, without confusing the patient.
  • scheduled packaging might provide one pill in the morning, one at lunch time, and two at night, in an attempt to maintain blood drug levels through the night.
  • regimens could provide higher initial dosages to build up blood drug levels, followed by lower maintenance dosages.
  • the patient simply takes, or is administered, at any given time, whatever dosage or dosages have been packaged into the bay 184 that is appropriately identified by patient, time and date. More subtle or more complex regimens will be apparent to those sldlled in the art, for example one drug might be discontinued, and possibly resumed after a suitable interval, while another continues.
  • Another useful technique to be able to administer via the dosage-scheduling package described herein is to taper down one drug while beginning to administer another, to provide a graduated switchover. Changing anticonvulsant therapies from one drug to another is an example of where this technique may be useful.
  • Prescriber-controlled dosage scheduling can be included in the system via an additional window or screen, offering the prescriber selection of the relevant variables, such as time-related dosages, with defaults or preferred selections for what can be system-determined as the most probable or most beneficial choices for the patient being treated, or accord with the patient's formulary's preferences or with the particular prescriber's preferences, pursuant to the principles described herein, pecific tapering or starting protocols can easily be implemented for outpatients decreasing the requirement for costly skilled supervision.
  • the time- and date-scheduled drug packaging described herein can be rendered electronically or electro-optically readable, for example with bar-coding or by using transparent compartments, to cooperate with a novel dosing indicator device that a patient could take with them to their home or on their travels, uch a novel dosing indicator device, as contemplated herein, includes a time-and- date clock and is designed to receive at least one scheduled dosage package, as described herein, and to inspect that package to determine what drug pills, capsules or the like have been removed.
  • Inspection sensing is preferably electro-optical and targets individual compartments with a light beam that is reflected or diffused by an individual pill or associated light-modulating tag, or by a bar code stamp or label which is required to be removed with each dosage of any drug.
  • the device can include a movable scanner that advances in relation to a package from one bay 184 to the next, scanning relevant compartments in the bay, as time passes, or it can comprise an array of photoelectric sensors registering with individual compartments of the package, which are electronically controlled and read in turn, as time passes. Equivalent sensing systems will be apparent to those sldlled in the art.
  • a preferred embodiment of dosing indicator device accommodates, within an aesthetically pleasing housing, a multi-bay scheduled dosage package, a time-and-date clock, a time-related sensor to detect the presence of a drug dosage in the bays one or more alerting systems, associated electronics which may include a microprocessor, and a power supply, for example, a battery, ac connector or remote drawdown source, or the like.
  • a dosing indicator device can be embodied as a motor-driven single- or multi- drug dosage dispenser which, for example, can house a tape, or strip-like and preferably rolled, scheduled dosage package, having a time line along the roll, and advances individual bays 1 84 containing one or more dosages for a given dosage time, and presents a single bay 184 (containing one or more dosages) for external delivery and removal (for example by tearing) by the patient, or patient's aid, in timed relationship to the dosage time (a half hour before, perhaps) and triggers one or more alerts if the bay 184 is not removed (a half hour after, perhaps).
  • a motor-driven single- or multi- drug dosage dispenser which, for example, can house a tape, or strip-like and preferably rolled, scheduled dosage package, having a time line along the roll, and advances individual bays 1 84 containing one or more dosages for a given dosage time, and presents a single bay 184 (containing one or more dosages) for external delivery and removal (
  • each bay is accompanied by written information as to the patient, time and date, each drug, and any relevant dosing instructions.
  • the individual compartments of such a removable bay cannot readily be sensed for the presence of individual pills.
  • a sensor is required for the presence of an externally exposed bay. The system assumes that the pills in a removed bay will be ingested, but this assumption may be wrong on occasion. More rigorous patient compliance may be exacted by including in, or in association with the device, a receptacle for an emptied bay 184 and triggering alert means if such emptied bav is not received within a specified time interval. Emptied bays can be retained within the receptacle. To deter deceit of the receptacle it can read a time and date stamp, or other unique identifier on bay 184.
  • a multipatient version of the drug dosage dispenser described herein can also be provided for inpatient use in medical or health care facilities, especially hospitals and clinics, uch a multipatient version could comprise a central dispensing station, located for example at a nurse's station.
  • the dispensing station can have multiple ports, preferably identified with bed locations and bed-occupants' names, whereby scheduled drug dosages for each bed-occupant patient are dispensed at scheduled dosage intervals, if desired with appropriate alerts or indicators.
  • Nursing or other staff can readily remove and administer the correct drug dosages for multiple patients, possibly on a single round, or at specific times of the day.
  • a further valuable feature of the novel prescription management system described herein is an ability to review a completed prescription for contraindications, or relative contraindications, such as patient allergies to the prescribed drug and such as possible drug-to-drug interactions with other drugs the patient has previously been prescribed.
  • Contraindications may be clear-cut, for example, penicillin must not be selected for penicillin-allergic patients, whereas relative contraindications are less decisive and may be overridden by the prescriber in appropriate circumstances, for example an N AID (non-steroidal anti-inflammatory drug) may be a preferred choice, in the prescriber's judgment for a patient with peptic ulcer disease, in spite of the attendant risk of ??
  • the system can also screen or review for other possible unintended adverse outcomes to the prescribed therapy, or for special precautions regarding a prescribed drug's use.
  • the system alerts the physician-user at the point-of-care if they prescribe an offending agent, and provides an alert and an opportunity to amend the prescription before dispatching it for fulfillment.
  • Processing to screen for interactions may occur on the user's point-of-care device or on the host computer facility or remote computer system, or may be delegated elsewhere by the host computer facility, and reported back to the physician, online as an integral function of the prescription process.
  • interaction screening may be run on pharmacy- related systems, and notification of problems can be sent immediately to the user's point-of-care device using e-mail or using procedures within the prescription management application of the invention.
  • An allergies review can be conducted by checking system-stored l ⁇ iown allergies of patient Mary Harrington against l ⁇ iown pharmacoldnetics and pharmacodynamics of the newly prescribed drug, entered in prescribing zone 44, for any of those allergies.
  • Mary Harrington's allergy information is preferably an adjunct to her patient record and is downloaded to the user device from host computer facility when Mary Harrington is selected from the patient selection screen of Figure 2.
  • Drug allergenic proclivities are also downloaded from one or another remote database employing the host computer facility, under supervision of the inventive prescription management system, but preferably at a later point in the procedure, such as when a particular drug is selected for posting to prescribing zone 44.
  • the requisite information can be downloaded when the allergy review is conducted, uch allergy screening can alternatively be effected when a new drug is posted to Drug field 88. Either way, a positive system finding, indicating a risk of allergic reaction to the newly selected drug can activate a visual indicator or warning, for example, Allergies button 52 may blink and, if desired, an audible warning may sound alerting the physician to reconsider their selection.
  • an alert screen can tell the physician of an allergy if an attempt is made to prescribe an offending drug, uch alerts can be used to notify the physician of drug interactions, treatment warnings or can alert them to non-compliance with formulary recommendations, for example to the use of an unnecessarily expensive drug, and may be accompanied bv suggestions for more appropriate alternative therapies.
  • Equivalent procedures can alert to possible drug interactions and contraindications, referring to the patient's prescription history for possible active or recently expired prescriptions that may interact with a newly prescribed drug, and for other patient data relevant to the drug's behavior in that patient. Alternatively, the such a review for possible undesired aspects of the drug's performance on the patient is made upon activating Send Rx button 80.
  • Activation of Send Rx button 80 can provide a drop-down menu of choices including " end this prescription” and "Add prescriptions prior to sending in a batch”.
  • a preferred embodiment of the invention includes a capability whereby a completed prescription is transmitted across one or more data networks for fulfillment and record updating in a wired or more conveniently, for mobile professionals, a wireless broadcast.
  • relevant remote source databases which may be proprietary
  • relevant remote source databases are updated with appropriate components of the new information and such updates are effected with proper controls to ensure data integrity, confidentiality and authenticity.
  • all transactions generate an audit trail and are authorized or preauthorized by the patient.
  • a "end Prescription" function outputs the prescription for fulfillment in any desired form, posts the completed new prescription to the prescription History zone 43 in the center of the screen, and outputs the new prescription from the user's station to update a control system or remote database, as desired.
  • Prescriptions can be electronically transmitted to a pharmacy or pharmacy-management system for fulfillment, or printed on paper for paper-based fulfillment by hand delivery or fax.
  • the inventive prescription management system embodiment disclosed herein is designed flexibly to facilitate a physician's prescribing activities, to place helpful information at their fingertips and reduce manual look-up chores, while avoiding any authoritarian direction, mandate or constraint upon a physician's professional activities or judgement.
  • the system may attempt to provide intelligent options and exhaustive selection lists, options such as "other" are always available to permit the prescriber complete freedom of choice, whether or not their choice is known to system-available databases.
  • Optional system enhancements provide for enrichment of external communications, for example prescriptions and e-mail with what may be termed "electronic ink” messages generated at the user device.
  • “Electronic ink” refers to notes or messages appended to external communications, or transactions in the form of free text or voice annotations for non-structured instructions, and the like.
  • Voice annotation is particularly convenient, as well as possibly constituting unique user-identification and some currently available low form factor user devices incorporate a microphone, facilitating voice annotation.
  • the system should have access to, and provide to its users fully comprehensive drug and patient information so far as this is available. Comprehensive, accurate and complete drug and patient information are equally important for effective prescribing. It follows that the drug and patient information source databases from which the prescription management system draws, must be maintained up to date, by appropriate network services.
  • the unique source-oriented information retrieval and updating system described herein provides preferred means for supporting the prescription management system of this invention with an adequate infra-structure of data-retrieval networks supplying a comprehensive array of up-to-date prescribing information and patient- related data to the point-of-care.
  • Other suitable information data retrieval and updating systems will be apparent to those sldlled in the art and can be linked to the system of the present invention to provide allergy and interaction alerts, formulary changes, new drug approvals, and to lock out or warn against, the prescribing of inappropriate or recalled drugs.
  • Drug and condition selection will be apparent to those sldlled in the art and can be linked to the system of the present invention to provide allergy and interaction alerts, formulary changes, new drug approvals, and to lock out or warn against, the prescribing of inappropriate or recalled drugs.
  • the condition list selection screen shown in Figure 4 appears upon activation of Condition field 86 in the prescription management screen of Figure 3, to enable a prescriber to approach selection of a treatment drug by first specifying a diagnosed condition.
  • a drug may be directly specified by drug name by activating Drug field 88, as will be described in connection with Figure 9, after which the prescriber selects a condition to specify the purpose of the therapy, uch condition or drug selection screens can be opened by similar condition or drug buttons in any other relevant screen or application, for instance in a patient encounter screen where the drug selection routines now to be described with reference to Figures 4 to 1 1 can be used to assist a physician to select or review treatment objectives in a computer-assisted patient encounter.
  • the condition list-selection screen of Figure 4 provides a preliminary selection of a suitable condition list from which a physician user can work to select a drug.
  • the screen comprises a Select Condition List title 1 10 and a Condition List display header 1 12 beneath which the names of Condition Lists 1 14 are grouped in a left-hand column.
  • a right-hand column beneath header 1 12 displays the conditions 1 16 of whichever condition list 1 14 is highlighted, or otherwise selected.
  • the user's personal condition list 1 14 has been highlighted and may be seen to comprise a short list of commonly occurring problems that, for example, a general practitioner might encounter.
  • Condition Lists 1 14 are available in this embodiment to provide a range of choices to physicians, and six are shown, by way of example. Three of these lists 1 14 classify conditions broadly bv diagnosis (Dx) and comprise a system- maintained Dx-Personal list 1 14, an alphabetically organized Dx-Alphabetic list 1 14 of all conditions in the system and a Dx-Category list 1 14. Dx-Category list 1 14 lists conditions by broad therapeutic category such as cardiovascular, GI or dermatology. A fourth condition, problem or diagnosis list, Dx-Patient list 1 14 lists previously exhibited conditions or problems of the selected patient, in this case, Mary Harrington. Dx-Patient list 1 14 is system maintained (and manually supplementable) and changes according to the patient selected in the patient- selection screen of Figure 2. Dx- Personal list 1 14 is also system maintained (and manuallv supplementable) and changes according to which prescriber signs on.
  • Dx-Patient list 1 14 is system maintained (and manually supplementable) and changes according to which prescriber signs on.
  • the system includes frequency counters to track the conditions the user encounters with time, and the counts obtained are used automatically to maintain or generate a Dx-Personal list 1 14 for the user, which more closely portravs patterns of conditions encountered in the user's practice as time goes by.
  • Base periods for reporting usage may be varied, or user selected, to list conditions encountered by frequency in, for example, the last year, the last five years, or perhaps, the last three months. Also, a default can be included to highlight a selected patient's last active condition or conditions as a first-line choice.
  • anv time a new diagnosis is made the new condition encountered is placed in the user's Dx-Personal list 1 14 and any time a drug is chosen it is placed in a personal drug list for the user.
  • the first time either a condition or a drug is selected it is added to a user profile stored on the network, for example, at the host computer facility.
  • a physician-user can manually maintain one or more custom lists, Dx- Custom 1 list 1 14 and Dx-Custom 2 list 1 14, for their own preferred short lists of conditions being, for example, conditions appropriate to their specialty that the individual physician frequently encounters for treatment.
  • libraries of specialty lists may be made available from which the user selects one or two lists for their personal use.
  • uch custom lists 1 14 mav be associated with different user activities, for example, Dx-Custom 1 could be used at a hospital where the user is an attending physician, while Dx-Custom 2 is used at a pain clinic where the user is a visiting physician.
  • the various condition lists 1 14 provide alternative pathways to drug selection that a physician may use as an aid to deciding upon a course of treatment. Different pathways may suit different clinical circumstances or prescribers. Availability of alternative routes to relevant drugs may enable a physician to find improved treatments, and increase their range of choices, and may lead to new solutions to difficult prescribing situations.
  • condition list selection screen shown in Figure 4 is a gateway to other condition and drug selection screens.
  • a preferred condition list typically a Dx-Personal list 1 14
  • a Change Condition List button not shown
  • condition lists 1 14 can be automatically supplemented or maintained by the system as it receives data in the course of processing numerous prescriptions for one or more physician users.
  • preferred embodiments maintain user profiles on a host computer facility which continually refreshes the data at the user's device so that the user can use any device or share a device with other users.
  • the patient condition 1 16 in the Dx Personal category shown comprise generalized groups of disease, some serious like diabetes and pneumonia, and others less so, for example rhinitis or sinusitis. More complex embodiments than the one shown here may categorize conditions into as many as four or five different columns of subcategories of condition according to disease pathology, therapy, personal knowledge and so on. uch condition categorization, as a preliminary to drug listing, provides a very powerful tool for physicians to view their prescribing options on screen and to organize them. Organization of drugs by lists of effectively treated patient conditions enables a user intelligently to access a large body of drug data selections. This approach provides multiple mapping so that the user can find a suitable drug or selection of drugs via different pathways according to their preferred work methods.
  • the user-physician has highlighted and selected a patient condition 1 16, namely, peptic ulcer disease (PUD)/gastritis, displaying, in the next right-hand column (see Figure 6), a short, system-generated list of drugs known to be therapeutically indicated for PUD/Gastritis and which may be suitable for prescription or to have been prescribed in the past by that user for treating these conditions.
  • PUD peptic ulcer disease
  • Figure 6 a short, system-generated list of drugs known to be therapeutically indicated for PUD/Gastritis and which may be suitable for prescription or to have been prescribed in the past by that user for treating these conditions.
  • the presence of the user's previously prescribed drugs which may not necessarily appear on third parties' lists, helps personalize the list to the user.
  • a condition-specific, formulary drug list 1 18 is displayed in the next right-hand column of the Select Condition screen of Figure 6 under Formulary Drug header 120.
  • a physician's personal list of drugs may be displayed with formulary drugs highlighted. If desired, relative cost information can be included or alternative drugs may be ranked by preference of the formulary manager.
  • Formulary Drugs are those listed by a drug formulary specified by, or relevant to, the patient, in this case, Mary Harrington.
  • the drug formulary may be generated by a prescription benefits management company and is a key ingredient in a system for reducing overall prescription costs bv using volume purchasing to get preferred -6-5- pricing on selected drugs.
  • a major problem in fulfilling the cost-control objectives of a managed care organization is that of informing a prescribing physician as to which drugs are in the formulary for a given patient. Noting that there are many different formularies it is quite impractical for the average physician to keep referencing different formularies for every patient every time they write a prescription.
  • the aspect of the invention shown in Figures 6 through 1 1 helps solve this problem by providing computer access of remote databases containing the information and by presenting available formulary drugs in a form which is easy for a physician to use, reference and prescribe without enforcing physician compliance with a formulary's treatment guidelines and attempting to restrict a physician's exercise of their professional judgment.
  • the system of this invention is designed to empower a physician to make informed choices at the point of care.
  • the system fosters quality, cost-effective prescribing. Physicians do not have to attempt to remember drug formularies and formularies may be changed with instant effect on all users without having physicians relearn the formulary.
  • formulary infonnation is called across a data-retrieval network, each time it is required, in accordance with preferred embodiments of the invention, from a remote source database, updates are automatically posted across the network.
  • Nonformulary drugs may be substantially more expensive than formulary drugs, or may not be covered by the patient's drug benefits plan, and may require out-of- pocket payments by the patient which circumstance may cause administrative problems to the physician and be a burden to the patient. Worse still, the patient may not have the prescription filled.
  • a patient prescription history can indicate whether a patient actually received a medication.
  • the physician can be alerted (by e-mail) if a patient has not filled a prescription for a critical medication, for example LA IX (Hoechst), prescribed for hypertension, enabling a follow-up with the patient to be initiated.
  • LA IX Hoechst
  • non-formulary drugs hould the physician know, for example, that cimetidine and ranitidine, drugs in a similar class, have been tried and found ineffective and that the condition is well beyond these first line treatments, so that none of the formulary drugs is suitable, then the physician can select Other, which selection displays a nonformulary drug list 122, under nonformulating drug header 124, as shown in Figure 7. In this case, the physician selects Sucralfate as being a non-formulary drug in a different chemical category and having somewhat different therapeutic properties from those previously applied to treatment of this patient's symptoms.
  • sucralfate is a nonformulary drug not on patient Mary Harrington's prescription benefit management company's schedule.
  • the doctor can, if appropriate, consult with a patient, explain the reasons for his or her drug selection and gain the patient's agreement to assuming the cost of the prescription, or obtain authorization from the plan to cover the cost of this prescription for this exceptional case.
  • Physicians manifesting increasing compliance flowing from use of a prescription management system according to this invention can expect ready approval of a non-formulary drug on a justified exceptional basis.
  • an expensive drug like captopril may be a first-line formulary choice for an acute condition such as congestive heart failure, but not a first-line choice, or may even be excluded as non-formulary, if prescribed for a chronic condition such as hypertension.
  • a physician will need to select a drug with which they have little or no experience.
  • the system provides major support and reassurance, presenting several different pathways to appropriate solutions enabling online access to the latest available scientific, clinical and commercial information about a new drug as well as screening for complications.
  • the ability to offer drug detailing at the point of need for new drug information can be used to attract revenue from pharmaceutical companies, managed care companies or others, and is especially useful in decreasing the barriers to switching to first-time use of a drug.
  • the system-provided prescribing information resources that are brought to the point of care are also valuable in enabling a physician to make quick therapeutic substitutions.
  • the drug selection screen shown in Figure 8 offers, by way of example, one route to selecting a new drug not on the prescriber's short lists.
  • selection is condition driven and proceeds with the selection of a condition list 1 14, Dx by Body System or Dx by Therapeutic Class, and then locating a drug to treat that condition; or alternatively, by directly selecting a drug via drug lists 1 15 Rx by Therapeutic Class or Rx by Alpha.
  • selection proceeds to the choosing of a drug to treat the condition of osteoarthritis.
  • Drug selection proceeds through a preliminary selection of drug category, from a list of drug categories 1 19 in the next column to the right, enabling the prescriber to choose their therapeutic approach, in this case, as between employing an analgesic, a narcotic, a N AID (non-steroidal anti-inflammatory drug) or a salicylate.
  • a NSAID is chosen, generating an extensive list of drugs 121 in the right most column in Figure 8, from which the prescriber can make their final selection which will be posted to Drug field 88 in the prescription creation screen 39
  • One preferred user-adaptive approach to providing a quick-prescribing pathway to a prescription is for the system to process the user's personal drug list, to highlight, or short-list or otherwise present those drugs on the personal list that are appropriate therapy for any of the patient's active conditions, and preferably also, that are on the patient's formulary.
  • an alternative direct drug-specification pathway commences, reading from left to right, with selection of drug list 1 15 Rx by Therapeutic Class. From a list of perhaps fifty to one hundred drug categories 1 19 which appears in the next right hand column, the prescriber has picked Diuretics, generating an even longer list of diuretic drugs 121 from which the prescriber has picked Dyazide (trademark, mith Kline Beecham). The system now calls for entry of a condition, in this case "hypertension”. The extent of the lists of drug categories 1 19 and diuretics 121 , again illustrates the bewildering array of drug selections with which a prescriber is confronted.
  • the selection program illustrated in Figure 10 provides a variety of pathways for direct drug selection via five drug lists 1 15, a personal, an alphabetic, a category list and two custom lists, analogous to condition lists 1 14.
  • the user has selected Rx-Alphabetic list 1 15 and the system has displayed a portion of a long, scrollable list of drugs 121 in the next column.
  • This approach can quickly locate a target drug when the physician knows it by name.
  • Cefixime has been selected and the system calls for, and requires, the prescriber to enter a condition before proceeding to quantification of the prescription.
  • the system lists conditions that the user has previously treated with Cefixime, highlighting the most recent condition so treated, or the system may display a previous condition of this patient that was treated with cefixime, not necessarily by the current user. If the physician wishes to attack some other condition with cefixime, such other condition may be selected from the last righthand column, activated by "other".
  • the diversity of conditions treatable with cefixime illustrates the potential for outcome studies based upon widespread use of systems according to the invention to refine definitions of the therapeutic scope of individual therapeutic agents by collecting data on effective new applications and on precautions, interactions and side effects.
  • the physician can eliminate many subsequent problems or difficulties which may lead to unnecessary paperwork, or surprised, annoyed or non-compliant patients, and to unnecessary phone calls between pharmacist and physician when a patient learns only at the pharmacy that their prescription is non-formulary.
  • the system can eliminate much unnecessary "phone tag" between pharmacies and physicians. Improved physician and patient compliance with preferred guidelines will reduce the cost of care and increase the quality of care.
  • prescription management system of the invention can provide a variety of printed reports and other data outputs of any facet of the described operations.
  • these reports can be enhanced to provide entirely new products for example a dosing schedule such as that described with reference to Figure 15, and shipping schedules or split prescriptions divided according to suppliers requirements.
  • a powerful optional feature of the invention is shown in exemplary fashion by the drug evaluation screen depicted in Figure 1 1.
  • the system can optionally scan a drug preference database of preferred drug treatments for an evaluation of the merits of the selected drug in treating the condition.
  • the drug preference database may be remote and may be maintained, for example, by a managed care organization, HMO, or prescription benefits management company.
  • HMO managed care organization
  • one possible result of the database scan may be an on-screen report with an alert message, in header 126 advising the physician that the selected drug is "Not a first line drug" for treating the selected condition.
  • the system can also offer alternative drugs, from listings in the drug preference database, as being more meritorious for the treatment of the condition in question (pursuant to the maintaining benefit company's standards or, preferably, to objective literature reports).
  • the drug selection evaluation screen of Figure 1 1 comprises an explanatory box 128 elucidating header 126; an alternative drug selection menu 130; and at the bottom of the screen, three action buttons; for example, Tx Guidelines 132 to access treatment information about the alternative drug highlighted in menu 130; a confirm button 134 to post the physician's original drug selection, in this case "Cefixime” and to return to prescription creation screen 39; and a cancel button 136 which returns the user to the drug-selection of Figure 7.
  • Tx Guidelines 132 to access treatment information about the alternative drug highlighted in menu 130
  • a confirm button 134 to post the physician's original drug selection, in this case "Cefixime” and to return to prescription creation screen 39
  • cancel button 136 which returns the user to the drug-selection of Figure 7.
  • the treatment information available via Tx Guidelines button 132 may include a literature reference supporting the system's finding that Cefixime is not a preferred first line agent for treatment of the selected condition, otitis media.
  • Tx Guidelines button 132 can provide the user with an access point to full disclosure and prescribing information on the drug.
  • Available treatment guidelines information can include details of the particular conditions for which a system suggested alternative drug has been found effective, adverse conditions, preferred dosages and administration routes, literature sources and so on. This aspect of the inventive system provides a simple, nonintrusive technique for bringing new drug information to physicians at a critical moment of need, when creating a prescription.
  • the prescription review system exemplified in Figure 1 1 has great value as an educational tool. Physicians can be subtly trained to improve their drug selection behavior. By using the system aggressively and exploring its information resources, as they are encouraged to do by the system's prompts and alerts, physician prescribers effectively receive education and training at the point of care. Improvements in drug therapy are subtle and complex and it is often difficult, even for the most conscientious of physicians, to be abreast of developments in any more than one narrow field of medicine. It is just as difficult for purveyors of new drugs to break in to a physician's packed work schedule to educate them as to the merits of a valuable new drug.
  • the physician user may choose to display a screen of drug information regarding the alternative drug or any other drug. After confirming a drug selection the system can review the patient's history in relation to the selected drug and alert the physician to any relevant allergies, one-on-one drug interactions or, if appropriate, multiple drug interactions.
  • This invention solves that problem by presenting new drug information in a timely manner at the moment when it is most needed and a physician is most interested in considering it, namely at the time of writing a prescription. It gives a benefit management company the opportunity to influence a physician's choice at the most influential moment, during the prescribing decision.
  • the system of the invention can provide a novel approach to drug formulary management whereby prescriber-centric formularies can be established.
  • drug formulary guidelines effectively adapt to the user's prescribing patterns or can be followed effortlessly by the prescriber.
  • This desirable prescriber- centricity can be obtained by giving priority to the prescriber's personal or custom lists or, better still if they are a subset of these, to the patient's history lists, and system-identifying patient-formulary preferences on those lists for easy final picking by the prescriber.
  • the prescriber is selecting a drug providing effective therapy for a just-specified condition, the above procedure may often clearly identify a single drug meeting all requirements or may result in a short list of a very small number of drugs for final selection.
  • the system may so alert the user and suggest formulary drugs not on the doctor-specific lists or ask the user whether thev wish to review appropriate non-formulary drugs from their personal or custom lists.
  • Figure 12 shows a prior prescription information screen which can be displayed by double clicking the prescription display line or activating RX History button 54 in a screen zone such as prescription history zone 43 of prescription creation screen 39 shown in Figure 3.
  • the embodiment of screen shown in Figure 12 provides a simple passive information display, comprising an information box 138, a close button 140 and a scroll bar 142 for scrolling or browsing a library of prescription histories.
  • the displayed prior prescription information in box 138 comprises, for the selected prescription, the condition for which the drug was prescribed, the drug name, date of prescription, dates of any renewals and the name, phone number and any other appropriate identification of the prescribing physician, in this case it is the user physician, and any other useful details that may not be strictly prescribing information, including appended free text, voice annotations or other electronic ink.
  • an "N" indication appears in the Mine column 76 on the prescription history line in Figure 3, the name of another physician who authored the relevant prescription will appear in Figure 12.
  • Additional options include a display of historical dosage information and an ability to page through all prior prescriptions or all prescriptions for a given patient, a given prescriber, a given condition, a given therapeutic class, and so on, recapping some of the functionality of the Figure 3 prescription creation screen 39.
  • a further optional feature of the invention is shown in the patient problem or condition screen of Figure 13, openable, for example, from Problem button 50,
  • Figure 3 which trades, as indicated by the field headers 144- 156 extending across the screen, a history of the patient's problems and records diagnostic determinations regarding individual problems, in particular, the system captures information regarding the date when a new problem first becomes active and when it is "deactivated". These dates are associated with the name of a physician user, and thence with a patient encounter and can be regarded as authentic diagnostic determinations capable of being substantiated from the physician's office records. Additional information screens, detailing, for example laboratory or other diagnostic data, or relevant personal patient characteristics, for example height and weight, can be linked to problems as they are with drugs.
  • Problems that no longer manifest themselves to the patient or physidan can be indicated as not active in Act field 148.
  • the problem list can be sorted by header selection and preferably presents active problems at the top of the list by default.
  • a system-maintained problem list provides an easy and convenient reference to the patient's history of conditions or problems and of the duration and currency of such problems and constitutes a valuable case management tool for physicians.
  • the problem list is automatically supplemented during the prescribing process with the latest prescriber's latest observations and diagnoses, as indicated by selection of one or more conditions for posting to a new prescription.
  • a quick prescription creation routine comprises selecting the problem from the Dx-Patient list 1 14, then selecting a drug from a system-generated pick list of drugs providing appropriate therapy for that condition.
  • the pick list is preferably drawn from the doctor's personal list and is either compliant with the patient's formulary guidelines, or indicates those guidelines, for example by inverse video, highlighting or the like, and also includes a selection of "other" to access drugs not on the prescriber's personal list, uch a quick prescription routine enables the most routine situations to be promptly handled, yet permits the physidan to expand their prescribing horizons and does not merely require selection of the same drug as was used previously. Quick treatment substitutions are made possible by the system's ⁇ presentation of available alternative therapies enabling the icsc ⁇ oer easily to see what alternatives are available and to explore those with which they are unfamiliar.
  • problems or conditions on this list can be automatically posted to a patient problem list 1 14 to appear as an additional "Dx" list in screens such as those shown in Figures 4- 10, to provide quick selection or review of a patient's historical conditions.
  • a Dx-Patient list 1 14 changes automatically when another patient is selected.
  • the problem list screen of Figure 13 is accessed from prescription creation screen 39 ( Figure 3) by pressing button 50. electing an OK button 158 or Cancel button 160, the problem list returns to prescription creation screen 39 ( Figure 3).
  • Change Status button toggles the highlighted Act entry between "Y' and "N", and records a date and physidan name with any status change.
  • Add button 1 64 enables a physidan user to add a new condition to the list, using condition selection pick lists, as previously described. This routine may be used to note problems for which there is no spedfic prescription given, e.g. obesity or senile dementia.
  • inventive prescription management system is applied to statistical data collection for outcome studies, it is preferable to supplement the patient record with a range of relevant personnel data, to the extent that this is available, for example drug abuse behavior, smoking and habitual eating or drinking behavior, dietary habits, marital and family status, pregnancies, ethnicity, environmental factors, and so on.
  • relevant personnel data for example drug abuse behavior, smoking and habitual eating or drinking behavior, dietary habits, marital and family status, pregnancies, ethnicity, environmental factors, and so on.
  • the system provides an excellent means for tracking these factors and their changes as they may pertain to an individual's health. For example, data fields could be added to record any of the foregoing data and the data could be updated by medical or administrative personnel in preparation for a patient-physidan encounter.
  • death certificate information Of particular significance to outcome studies will be death certificate information, and preferably this information is added to the patient problem record of Figure 13, as appropriate.
  • More complex embodiments of the invention can integrate applications for prescription management with equivalent applications for diagnostic tests, laboratory analyses, and radiological studies to provide a more comprehensive patient history viewable in multiple screens.
  • laboratory results providing drug dosing levels, renal and liver function tests that provide important indications as to appropriate dosing, and so on.
  • Figure 14 shows a manually maintainable problem record maintenance screen, for physidan use, which can be accessed for example from the Doctor's lists button 24 in the system entry screen of Figure 1.
  • This screen enables a doctor or physidan manually to maintain their own personal customized prescription, diagnosis, allergy or other useful lists, to supplement the automatically maintained system lists. If desired, problems the doctor's patients have experienced previously can be system- added to the list, for example when a patient is selected.
  • the problem record maintenance screen of Figure 14 comprises a Problem List box 166, a List Type box 168 and a Problems box 170 displaying a comprehensive, or preferably exhaustive list of problems which can be selected and transferred to the network and the physician's problem list by pressing update button 172. Highlighted entries can be removed from the Problem List 166 by pressing delete button 174. ave button 176 and Exit button 178 perform the usual functions, and preferably provide options to cancel changes, and the like. Data entry box 1 80 permits an unlisted condition to be keyed in, or otherwise entered character-by-character and paging buttons 142 move between lists.
  • the data logged into archives comprise all data relevant to a patient's diagnosis and therapies, data relevant to the user's prescribing activities, including the prescriber's relevant electronic communications ("e-mail") with third parties (pharmades, laboratories, other health care providers, or potential providers, to the patient, and so on) and access audit data as to parties accessing the patient's or prescriber's personal data.
  • e-mail electronic communications
  • the lefthand side of the diagram shows an arrangement of services and devices that provide a downstream flow of data and communications resources to users of the prescription management, or other system described herein.
  • the righthand side shows sources from which desired data and data elements mav be drawn and pathways for those data to reach the user, the flow being marshalled by a centrally depicted host computer.
  • FIG. 16 hown schematically in Figure 16, are a number of user interface devices 200 and a desktop computer 201 communicating via any of a variety of communication services 202, through a gateway-router 204 with a host computer facility 206.
  • the drawing depicts schematically how a group or pool of users worldng with interface devices 200 or computers 201 , running the prescription management software of this invention, can be serviced by host computer facility 206.
  • host computer facility 206 Those skilled in the art will appredate that the schematic layout shown in Figure 16 is described in terms of its logical architecture and that the actual physical disposition of elements may be quite different.
  • gateway-router 204 can manage supplementary services such for example as a paging service 208 or any other relevant desired function.
  • Interface devices 200 are depicted as small form factor, handheld devices, or PDA's, communicating wirelessly over a WAN, a proprietary wireless service, or a cellular digital packet data service, or the like.
  • Desktop computer 201 which may be a portable, notebook or other higher form factor computer, connected to communications gateway-router 204 via a local area network labeled LAN, which connection could equally well be via modem, infra-red, wireless or the like, depending upon the circumstances. Any suitable network may be used, depending upon the user's equipment and the location of desired resources. Wired or wireless, local or wide area networks, or mixed networks, are suitable.
  • communications gateway-router 204 which is networked or otherwise connected with host computer facility 206.
  • Other prescribers may use different methods to communicate with host computer facility 206 using a two-way digital data communication svstem across a network.
  • Communication services 202 can be any service providing effective two-way data transfer between users 200 and host computer facility 206. As labeled, some possible communication services 202 are wired local area networks “LAN,...LAN n “, wireless local area networks “WLAN,...WLAN I .” and proprietary radio frequency packet data networks, such as A DI and AM (trademarks of their respective proprietors), cellular digital packet data networks "CDPD,...CDPD n " and so on.
  • LAN n could comprise a single desktop computer or a facility-based networked system of multiple desktop, or other computers.
  • Communications gateway-router 204 manages communications through these various media services and provides consistent interfaces to users at devices 200 and to host computer fadlity 206, regardless of which communication service 202 is used.
  • host computer facility 206 can comprise a client-server system in which a file server or database management server, or cluster of such servers, manage data storage and traffic functions, providing high volume data availability to multiple intelligent clients linked, typically over a local area network, to the server or servers.
  • Exchanging data, programs and processing services across this system, user interface devices 200 and host computer facility 206 support applications such as the prescription management system of the invention, E-Mail services and any other desired applications, for example patient encounter management programs, diagnostic procedure management programs, and the like, in an analogous manner to conventional client-server supported operation of such applications.
  • applications such as the prescription management system of the invention, E-Mail services and any other desired applications, for example patient encounter management programs, diagnostic procedure management programs, and the like, in an analogous manner to conventional client-server supported operation of such applications.
  • Host computer fadlity 206 provides intelligent network services to user devices 200 and 201 and may support andllary services, especially for example, as described hereinbefore, patient-directed data access control software.
  • Prescriber-directed data access control software or organization-directed data access control software could also run in an application separated from the prescription management system, but is preferably integrated therewith as a component of a user initialization routine.
  • patient interface components of the patient-directed data access control software are run at separate stations from the point-of-care locations used by prescribers and are located, for example, in administrative or reception areas of health care facilities or managed care organizations.
  • data access rights may be read off a patient's data access control card, and such cards may be issued, under control of software supplied by, and in communication with host computer facility 206.
  • interfaces devices 200 can be varied according to their physical capabilities and user or system administrator preferences. At a minimum, and for device redundancy, interface devices 200 need have resident neither files nor software, beyond what is supplied with the device off the shelf.
  • the user interface device may establish communication with host computer fadlity 206, using a separately supplied electronic address for that facility and may upload necessary program components and data files, including such personalized user profiles as have been established by the user's prior experience with the system and which have been stored at the host computer facility 206, are called from a remote host computer fadlity supporting other users.
  • basic system access software is required to be installed on the user device before system resources can be accessed. uch basic system access software can be activatable after reported loss or theft to disable system access capabilities and to render any stored proprietary data inaccessible to unauthorized users.
  • Host computer fadlity 206 provides full software support for user interface devices 200 and maintains complete program files for the prescription management system along with e-mail services and any other non-personal applications that may be needed by users of devices 200 beyond the basic operating systems and utilities, and the like, with which the devices are originally equipped.
  • Host computer fadlity 206 maintains databases of patient information for patients encountered or whose records have previously been viewed bv users of devices 200 in response to calls sent via host computer facility 206, (and logged by it for audit purposes) but, in keeping with the preferred practice of the present invention, host computer facility 206 does not maintain patient records in permanent storage. It could however be used to maintain patient record components that are source components to users of devices 200 for which this particular host facility 206 is, at it were, their "home" facility.
  • Important functions maintained by the host computer facility 206 are information locator databases and advanced directory and routing services, including the following: i) a user device and system registry enabling communications to be routed to the target user; ii) a patient information directory service enabling access the system to access remote databases to retrieve patient record components for compilation of virtual patient records as described above; iii) archiving of transaction logs and records, and of audit logs; iv) patient drug formularies and formulary guidelines or locators to access same; v) libraries of alerts and other system displayed messages; and vi) access control software and related data files for patients, care providers and organizations.
  • Drug and condition lists and some drug information are also maintained on the host computer fadlity 206, but these are preferably either synchronized or refreshed at intervals (e.g. overnight) from source databases of such drug information. More detailed drug information (e.g. U. . Pharmacopeia information) can be retrieved from remote databases by host computer facility 206. Host computer facility 206 also maintains directory services for accessing such drug related information, formularies, guidelines alert messages and the like and updates this data remotely from source databases maintained by the proprietors of the information.
  • More detailed drug information e.g. U. . Pharmacopeia information
  • Host computer facility 206 also maintains directory services for accessing such drug related information, formularies, guidelines alert messages and the like and updates this data remotely from source databases maintained by the proprietors of the information.
  • host computer facility 206 can off-load data- processing functions from interface devices 200, or conduct such functions in background to provide support for the relatively limited processing capabilities of devices 200.
  • a further important function of host computer facility 206 is to retrieve multiple elements of a single patient record from multiple heterogenous remote databases and to deliver them to users for assembly into a virtual patient record by an interface device 200 or 201 , in response to the user's call for that record.
  • Host fadlity 206 can reach out nationally, or internationally, for example across the INTE NET (trademark) to multiple remote databases such as remote databases 210 shown on the right hand side of Figure 16, to provide to users of interface devices 200 data resources beyond (and potentially more current than) those available from direct storage in the device or at the host facility.
  • INTE NET trademark
  • remote databases 210 shown on the right hand side of Figure 16
  • host computer facility 206 Communications Communication between host computer facility 206 and remote databases 210 will usually be via wire lines such as telephone, or local or wide area network communication via copper line, or optical fiber, or any other suitable communication medium.
  • host computer facility 206 can access any remote third party database with which appropriate arrangements have been made, or can be made on line, and some possible source databases for patient records components are labeled as "HMO's, Hospitals Insurance, Drug Benefit Cos, Pharmades, Labs and Independent Physidans". Drug information may be additionally sourced from pharmaceutical companies' research centers, reference libraries, or publishers and the like.
  • One or more pools of users of devices 200 and computers 201 constitute a valuable professional audience and the system provides a valuable means enabling such third party database proprietors to become data publishers and electronically publish or post their databases or on the network to reach that audience.
  • host computer facility 206 forages across available networks for similarly identified record elements to retrieve.
  • host computer facility can retrieve a variety of data including patient-spedfic data, application-spedfic data (users preferences and the like), organization-spedfic data (formulary guidelines, for example) and general drug or prescribing data, e.g. from MEDLINE.
  • this embodiment of the invention provides, at each of a limited number of remote databases 210 l ⁇ iown to be a significant source of patient record elements, a dedicated data warehouse 212.
  • Data warehouses 212 can be real or functional, depicting either actual physical embodiments of system-dedicated services located at the facilities of remote databases 210, or logical functions executed at the host computer facility 206.
  • Data warehouses 212, host computer facility 206, communications router-gateway 204 and communications services 204 are components of a conceptual integrating network 214 which brings users of devices 200 and 201 transparent access together with the resources available at remote databases 210, and preferably gives those users a seamless appearance, as though data stored piecemeal at multiple remote databases 212 were directly available from a single file across a local area network.
  • the system provides uniform application programming interfaces, remote API's 216 for use by third party developers.
  • Compatible user API's 218 on the downstream side provide similar standardized connectivity with user devices 200 and 201.
  • Integrating network 214 and API's 216 and 218 permit easy system integration, allow third parties to develop end-to-end communications solutions with standardized third party communication across the network and a data "firewall" for security.
  • Each data warehouse 212 maintains replicated copies of relevant data sets obtained by read-only access of remote databases 210, which data sets are maintained synchronously with updated source data at remote databases 210, or are periodically refreshed therefrom, preferably at frequent intervals.
  • Data warehouses 212 can also provide search and retrieval facilities and, in particular, provide protocol interchange and reformatting capabilities to reformat or otherwise standardize data and communications across network 214, for any application to use.
  • data warehouses 212 screen data incoming from assodated data warehouses 210 for date-stamping, and preferably, also time-stamping, of individual received data or record elements, and reject those that lack such stamps.
  • the date stamp indicates origination, creation or updating of the data element, rather than being merely a date of entry of the data element into data warehouse 212.
  • remote databases 210 can be directly posted to remote databases 210 across network 214 which bears two-way traffic.
  • remote databases also include data from other places, for example pharmacies, laboratories and testing facilities.
  • Communications gateway-router 204 also maintains a physician-device directory providing routing or access information needed to establish communication protocols with each individual physidan.
  • This device directory service can maintain an electronic address, a device identifier or device configuration, operating system information and user device communications protocols for each user device supported by the gateway-router.
  • User ID's can be listed separately and in preferred embodiments are accompanied by a prioritized listing of one or more device addresses where the user may be accessed.
  • an individual host computer facility 206 can serve one group of users that may, for example, be defined geographically and may number from, for example, as low as 10 or 20 users in the early days of establishment of the fadlity to hundreds and thousands as the facility matures.
  • additional host computer fadlities 206 can be established as centralized or regionally distributed hubs, uch additional host computer fadlities 206 will, in all likelihood, access many of the same remote databases 210.
  • switching or rerouting means are provided to optimize data traffic loads between multiple host computer facilities 206.
  • a national or international network can be created by establishing a sufficient number of host computer fadlities 206 in strategic locations, each serving a local client base of, for example campus or regional users, with interface devices 200.
  • Preferred embodiments of the invention include quick and easy routines for directly posting a drug to a prescription, without prior condition selection, such routines preferably being by-passed.
  • routines preferably being by-passed.
  • the treatment objective can be rapidly selected from a system-supplied list of a patient's existing or historical conditions, or through powerful system-aided selection of a new condition. While a default patient condition or problem may be suggested by the system for a particular prescribed drug, it is preferred that such default be actively confirmed by the prescribing user before being accepted by the system.
  • Drug field 88 of the prescription creation screen of Figure 3 can open a personalized or customized user-activatable drug list, or proceed to comprehensive system drug lists to enable rapid specification of familiar or unfamiliar drugs prior to condition selection. Drug dosage selection then proceeds as described above. Before leaving prescribing zone 44 of the prescription creation screen 39 the system can require an appropriate entry to be made in Condition field 86.
  • Other preferred embodiments enable the patient, the prescribing physician and the relevant organization to control the flow of their own data by predetermining access rights to that data. Every transaction can be stamped with a patient identifier, a prescriber identifier and, if appropriate, an organization identifier, as well as with the date and time of day.
  • User software components of a currently preferred embodiment of prescription management system described herein are designed to run under an operating system that preferably supports a full or modified version of M -DO ® (trademark, Microsoft Corporation) WINDOW TM (Microsoft Corporation) or other systems with user-friendly graphical interfaces, for example Apple Computer Co.'s MACINTO H (trademark) or NEWTON (trademark) operating systems and General Magic's MAGIC CAP operating system.
  • M -DO ® trademark, Microsoft Corporation
  • WINDOW TM Microsoft Corporation
  • Other graphical environments can be used or are being developed and other embodiments of the invention may be suitably modified to optimize the application to take advantage of the unique characteristics of each such operating system environment.
  • the programming language used to write svstem software depends upon the environment of the various system components. In their present stage of development, some handheld PDA's require applications to be written with the tools provided by their respective operating systems such as NEWTON or MAGIC CAP (trademarks). For other devices such as those supporting Microsoft's WINDOW (trademark) operating system, including some PDA's, a range of languages can be used including for example, popular programming languages such as Microsoft Corporation's "C” or Borland International's "C+ + ". For Apple Computer's MACINTO H (T ADEMA K)-based systems, languages such as THINK (T ADEMA K) are appropriate.
  • the system is particularly advantageous when implemented on any of a variety of portable computer stations especially handheld units such as personal digital assistants and other personal information communicators equipped with wireless communicators.
  • a preferred embodiment for mobile professionals comprises such a handheld unit with two-way radio or infrared communication fadlities.
  • ome such devices are referenced in a "BUYE ' GUIDE: PE ONAL DIGITAL A I TANT " PC WEEK August 29, 1994, pages 89 and 94 the disclosure of which is hereby incorporated herein by reference thereto.
  • the prescription management system of the invention is preferably designed to minimize the storage and processing requirements placed on the user's terminal and to off-load storage and processing to host computer fadlities.
  • the system's support architecture aims to supply to the user terminal only essential data required for screen displays and other user functions, on an as-needed basis, while the network stores applications and data files, for example at the host computer facility.
  • laboratory test information can be presented to a prescribing professional by first listing patient conditions which the professional wishes to explore more fully by specifying one or more specific laboratory tests, by reporting the laboratory result and suggestingizi ner testing for differential diagnostics.
  • the system then provides a selection of laboratory tests l ⁇ iown to be useful in evaluating the relevant condition, that selection and organization of laboratory tests being made in a manner similar to that described for therapeutic drugs in the preferred embodiments herein, and moves on to create, select and order appropriate cost-controllable diagnostic testing, in a comparable manner to that described herein for creating a prescription.
  • an analogous diagnostic application may provide cost-effective routes to rule in or rule out specific diagnoses.
  • the specificity and sensitivity of individual procedures can be translated into positive predictive values and negative predictive values.
  • diagnostic protocols can be worked up and maintained with current recommendations. Evaluation of the patient's history can enable pretest probabilities to be established and used to modulate the predictive value of one or more tests.
  • the patient's history can drive the selection and establishment of an optimal diagnostic test matrix for identifying a patient's condition or conditions with good specificity and confidence levels.
  • Test requirements relating to patient preparations, fasting for example, and sample collection can be system specified.
  • system-maintained identifiers e.g. bar code labels
  • a chain of evidence for rigorous sample accessioning can be begun.
  • a range of possible conditions can be evaluated in a differential diagnosis format designed to rule in or rule out a target condition, or conditions, depending upon the results of specified tests.
  • the patient wall be an animal such as a pet dog or cat or valuable livestock, such as a steer or breeding pig or a race horse or breeding stallion.
  • the invention provides a service professional with significant new benefits, especially during a service encounter with a customer or client, in selecting, specifying or providing technical remedies to consumer problems.
  • a service technician can benefit from an automotive service management system according to the invention in which a database of replacement parts is classified according to the service problem for which the parts might provide a remedy.
  • the system may provide a list of parts, for example, brake pads, brake pins, brake shims or brake rotors, any of which may provide a remedy to the customers problem of brake squeal.
  • Existing systems permit a service technician, having once identified the type of part they need, to obtain a number or part price and inventory on that part for the customer's specific model of car.
  • inventive system can provide access to technical literature on relevant problems, for example an explanation of the factors causing brake squeal which can be printed out for customers. This is a rather simple example. More complex examples will be apparent to those skilled in the automotive and other arts, espedally as this art develops, with sophisticated engine management and other microprocessor controlled systems raising new problems and new technical solutions being required.
  • inventive system can provide customer problem lists useful for outcome analysis to drive the development of better cars.
  • equating a parts supplier, such as a factory or warehouse distributor with a plan benefit company is the ability to provide new product descriptive and price information or updates from multiple sources dynamically, in real time as transactions are created.
  • a benefits company can apply practical selection guidelines in an unobtrusive manner to the prescribing process, an equivalent technique can be used by car factories to help control warranty service decisions at their dealerships.
  • possible insurance vendors and coverage information mav be classified according to customer problems so that, for example, an insurance agent mav list different vendors and coverage providing specific technical remedies to a customers spedfic; problem, for example, a recent major automobile collision claim.
  • the relevant novel supportive database could include information differentiating between parties at fault, collision damage, personal injury settlements and so on. In both these examples a problem history related either to the customer or to the customer's automobile can also be created.
  • systems and software referenced herein include, either explicitly, or implidtlv, software implemented on computers or other appropriate hardware, including user devices such as the personal digital assistants described herein, and such other intelligent data processing devices having a processor, data storage means and the ability to support an operating system, with or without user interfaces (for example, file servers,), as may be useful in achieving the objectives of this invention.
  • Preferred embodiments of the invention provide such media-stored software in a commerdal package accompanied bv instructions in printed book or booklet form, for deployment of the software on particular embodiments of general purpose computer to cause same to operate as a special purpose computer, in accordance with the objectives of the invention. License agreements, and registration means for updating mav also be included. Alternatively, the instructions may also be provided as data files.
  • such media-stored software constitutes an electronic customizing machine which can interact with a magnetically or optically cooperative computer-based input device enabling the computer to be customized as a spedal purpose computer, according to the contents of the software.
  • the software of the invention can be installed by a user, or other, and will usually interact effidently with the device on which it is resident to provide the desire special-purpose qualities, only after selection of configuration parameters.
  • the special-purpose computer device has enhanced value, especially to the professional users for whom it is intended.

Abstract

Système électronique de gestion (fig 16) par radio des prescriptions fonction de l'état des malades destiné à un médecin, regroupant les dossiers des patients (10), garantissant la confidentialité (39) et fournissant: une liste des contre-indications, des informations complètes en direct sur les médicaments (50) et la littérature scientifique, des annexes sur les nouvelles associations de médicaments, des systèmes d'administration et un 'réseau intelligent' de recherche à distance d'informations ( fig 16). Est également prévu un échange d'informations entre médecins par courrier électronique.
EP95937691A 1994-10-28 1995-10-27 Systeme de gestion des prescriptions Withdrawn EP0800680A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33074594A 1994-10-28 1994-10-28
US330745 1994-10-28
US08/330,939 US5737539A (en) 1994-10-28 1994-10-28 Prescription creation system
US330939 1994-10-28
PCT/US1995/014118 WO1996013790A1 (fr) 1994-10-28 1995-10-27 Systeme de gestion des prescriptions

Publications (2)

Publication Number Publication Date
EP0800680A1 EP0800680A1 (fr) 1997-10-15
EP0800680A4 true EP0800680A4 (fr) 1998-08-12

Family

ID=26987426

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95937691A Withdrawn EP0800680A4 (fr) 1994-10-28 1995-10-27 Systeme de gestion des prescriptions

Country Status (7)

Country Link
EP (1) EP0800680A4 (fr)
JP (1) JPH10508131A (fr)
AU (1) AU3972295A (fr)
BR (1) BR9509357A (fr)
CA (1) CA2201311A1 (fr)
MX (1) MX9702723A (fr)
WO (1) WO1996013790A1 (fr)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0813155A1 (fr) * 1996-06-10 1997-12-17 Smithkline Beecham Corporation Méthode et système destinés au traitement de maladies
CA2257537C (fr) * 1996-06-11 2005-01-25 Yeong Kuang Oon Technique de resolution de problemes iterative
US5976082A (en) * 1996-06-17 1999-11-02 Smithkline Beecham Corporation Method for identifying at risk patients diagnosed with congestive heart failure
DE19627464A1 (de) * 1996-07-08 1998-01-15 Siemens Ag Prozeßautomatisierungssystem
US5924074A (en) * 1996-09-27 1999-07-13 Azron Incorporated Electronic medical records system
US5980078A (en) * 1997-02-14 1999-11-09 Fisher-Rosemount Systems, Inc. Process control system including automatic sensing and automatic configuration of devices
EP0965095A1 (fr) * 1997-03-03 1999-12-22 University Of Florida Procede et systeme de prescription et de distribution interactives de medicaments dans des etudes medicales
GB2325760A (en) * 1997-05-28 1998-12-02 Kenshodo Pharmaceutical Limite Computer-aided prescription of herb medicines
AU9028498A (en) 1997-08-22 1999-03-16 Deka Products Limited Partnership System, method and cassette for mixing and delivering intravenous drugs
WO1999010829A1 (fr) * 1997-08-22 1999-03-04 Deka Products Limited Partnership Systeme de sante et procede de saisie d'ordonnances medicales
US6622036B1 (en) * 2000-02-09 2003-09-16 Cns Response Method for classifying and treating physiologic brain imbalances using quantitative EEG
US6915265B1 (en) * 1997-10-29 2005-07-05 Janice Johnson Method and system for consolidating and distributing information
CA2255291A1 (fr) * 1997-12-08 1999-06-08 Kopel H. Cohen Systeme automatise de commande de medicaments prescrits axe sur base de donnees
EP0923040A3 (fr) * 1997-12-12 2002-01-02 Texas Instruments Inc. Système d'information digitale et dispositif portable pour ledit
AU2673599A (en) * 1998-02-27 1999-09-15 Thomas L. Kapp Pharmacy drug management system providing patient specific drug dosing, drug interaction analysis, order generation, and patient data matching
US6024699A (en) 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6148297A (en) * 1998-06-01 2000-11-14 Surgical Safety Products, Inc. Health care information and data tracking system and method
US6045501A (en) 1998-08-28 2000-04-04 Celgene Corporation Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
WO2001037138A2 (fr) * 1999-11-15 2001-05-25 Walgreens Co. Dispositif et procede permettant d'acceder a des informations pharmaceutiques et de commander des ordonnances
US6947900B2 (en) * 2000-01-06 2005-09-20 Drugstore.Com Method and apparatus for automatic product listing
AU2001253879A1 (en) * 2000-03-31 2001-10-15 Disease Management Systems, Inc. Web-based medication management system
JP3984000B2 (ja) * 2000-05-31 2007-09-26 株式会社東芝 生産システム及び生産方法
US9135393B1 (en) 2000-08-02 2015-09-15 Smiths Medical Asd, Inc. Processing program data for medical pumps
US6315720B1 (en) * 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
AU2002224077A1 (en) * 2000-12-07 2002-06-18 Seiji Iwasaki Handled information registeration relay system
US6799149B2 (en) 2000-12-29 2004-09-28 Medtronic, Inc. Therapy management techniques for an implantable medical device
AU2002243347A1 (en) 2000-12-29 2002-07-16 Medtronic, Inc. Non-conformance monitoring and control techniques for an implantable medical device
US7072725B2 (en) 2001-03-26 2006-07-04 Medtronic, Inc. Implantable therapeutic substance infusion device configuration system
US8065180B2 (en) 2001-04-02 2011-11-22 invivodata®, Inc. System for clinical trial subject compliance
US7873589B2 (en) 2001-04-02 2011-01-18 Invivodata, Inc. Operation and method for prediction and management of the validity of subject reported data
US6879970B2 (en) 2001-04-02 2005-04-12 Invivodata, Inc. Apparatus and method for prediction and management of subject compliance in clinical research
US8533029B2 (en) 2001-04-02 2013-09-10 Invivodata, Inc. Clinical monitoring device with time shifting capability
JP4759163B2 (ja) * 2001-05-10 2011-08-31 株式会社湯山製作所 調剤制御システム及び調剤制御方法
JP2003099535A (ja) * 2001-09-21 2003-04-04 Abc Drug & Pharmacare:Kk 薬物動態シュミレーション情報提供システム
JP2003099536A (ja) * 2001-09-25 2003-04-04 Higashi Nihon Medicom Kk 移動電子薬歴管理システム
JP4234342B2 (ja) * 2001-12-26 2009-03-04 パナソニック株式会社 部品実装装置の部品実装動作支援システム及び方法
US8321236B2 (en) 2002-02-01 2012-11-27 Walgreen Co. Method and apparatus for prescription processing
JP4150524B2 (ja) 2002-02-13 2008-09-17 株式会社リコー 生産管理方法及び生産管理プログラム
US7490049B2 (en) 2002-03-29 2009-02-10 Medco Health Solutions, Inc. Patient oriented point of care system and method
AU2003241480B2 (en) * 2002-05-16 2010-03-04 Scott Laboratories, Inc. User authorization system and method for a sedation and analgesia system
US7968569B2 (en) 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
USRE48890E1 (en) 2002-05-17 2022-01-11 Celgene Corporation Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
US7890350B1 (en) 2002-06-11 2011-02-15 Epocrates, Inc. Method for generating and transmitting prescription renewal request information
JP2004110532A (ja) * 2002-09-19 2004-04-08 Shinkichi Himeno 医療上の処方作成システム
US8404716B2 (en) 2002-10-15 2013-03-26 Celgene Corporation Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
US11116782B2 (en) 2002-10-15 2021-09-14 Celgene Corporation Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
US7283653B2 (en) 2002-11-26 2007-10-16 Siemens Aktiengesellschaft Method and system for supporting the evaluation of a picture of an eye
AU2002353435A1 (en) * 2002-12-12 2004-06-30 Mdg Medical, Inc. Medication administration system
JP2005049962A (ja) * 2003-07-30 2005-02-24 Fujitsu Ltd オーダ発行方法、オーダ発行プログラム及びオーダ発行装置
EP1528500A1 (fr) * 2003-10-28 2005-05-04 Chhabra International Ltd Système et méthode électroniques d'ordonnance
US20050177395A1 (en) * 2003-12-04 2005-08-11 Blomquist Michael L. Programming medical pumps with electronic standing order template
US8954336B2 (en) 2004-02-23 2015-02-10 Smiths Medical Asd, Inc. Server for medical device
JP4615255B2 (ja) * 2004-05-31 2011-01-19 エムエム・ホールディングス株式会社 医療情報アクセス管理システムならびに同システムにおけるアクセス権限管理方法
US7801642B2 (en) 2004-08-18 2010-09-21 Walgreen Co. System and method for checking the accuracy of a prescription fill
US9710866B2 (en) 2005-09-30 2017-07-18 Edge Medical, Llc System and method for processing a multiple prescription order
US8972288B2 (en) 2004-10-01 2015-03-03 Edge Medical Properties, Llc System and method for online matrix-based dosage scheduling
US9245304B2 (en) 2004-10-01 2016-01-26 Edge Medical Properties, Llc Manufacturing separable pouches with a center cut blade
US8914298B1 (en) 2004-10-01 2014-12-16 Edge Medical Properties, Llc System and method for integrated verification and assembly of multi-script pouches into a housing container
US9334096B2 (en) 2004-10-01 2016-05-10 Edge Medical Properties, Llc Multiple inspection system and method that inspects different medications
US9015058B2 (en) 2004-10-01 2015-04-21 Edge Medical Properties, Llc Matrix based dosage scheduling
US7690173B2 (en) 2005-09-30 2010-04-06 Edge Medical, Inc. Multiple prescription production facility
US9238518B2 (en) 2004-10-01 2016-01-19 Edge Medical Properties, Llc Inspection system and method with a control process that inspects different medications
US8266878B2 (en) 2004-10-01 2012-09-18 Edge Medical Properties, Llc System and method for verifying and assembling a multiple prescription package
US8789700B2 (en) 2004-10-01 2014-07-29 Edge Medical Properties, Llc System and method for communicating and inspecting a multiple tablet order
US10315450B1 (en) 2006-10-24 2019-06-11 Edge Medical Properties, Llc System and method for generating an integrated label for container housing multi-script pouches
US8146747B2 (en) 2004-10-01 2012-04-03 Edge Medical Properties, Llc Tablet dispensing container
US9141764B2 (en) 2010-11-12 2015-09-22 Edge Medical Properties, Llc System and method for online integrated multiple tablet ordering
US8074426B2 (en) 2005-09-30 2011-12-13 Edge Medical, Llc Multiple prescription package and method for filling the package
US8123036B2 (en) 2004-10-01 2012-02-28 Edge Medical Properties, Llc Pill assembly for pill packaging and delivery systems
WO2006056002A1 (fr) * 2004-11-26 2006-06-01 Iba Health Limited Systeme de gestion de medication prescrite a un patient
JP2006318254A (ja) * 2005-05-13 2006-11-24 Rishi Ro 自動在庫管理システム
US7403123B2 (en) * 2005-09-30 2008-07-22 General Electric Company Method and apparatus for displaying a patient worklist
US7734478B2 (en) 2005-10-18 2010-06-08 Walgreen Co. Method and apparatus for inter-pharmacy workload balancing using resource function assignments
US7765108B2 (en) 2005-10-18 2010-07-27 Walgreen Co. Method and apparatus for inter-pharmacy workload balancing
KR20070053601A (ko) * 2005-11-21 2007-05-25 김용우 약품 관리 시스템 및 방법
US20080126969A1 (en) 2006-08-03 2008-05-29 Blomquist Michael L Interface for medical infusion pump
US8149131B2 (en) 2006-08-03 2012-04-03 Smiths Medical Asd, Inc. Interface for medical infusion pump
US8858526B2 (en) 2006-08-03 2014-10-14 Smiths Medical Asd, Inc. Interface for medical infusion pump
US8965707B2 (en) 2006-08-03 2015-02-24 Smiths Medical Asd, Inc. Interface for medical infusion pump
US8435206B2 (en) 2006-08-03 2013-05-07 Smiths Medical Asd, Inc. Interface for medical infusion pump
US8037052B2 (en) * 2006-11-22 2011-10-11 General Electric Company Systems and methods for free text searching of electronic medical record data
US9171344B2 (en) 2007-10-30 2015-10-27 Onemednet Corporation Methods, systems, and devices for managing medical images and records
US8380531B2 (en) 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
JP2010035885A (ja) * 2008-08-06 2010-02-18 Ricoh Co Ltd 情報記録媒体及び服薬支援システム
US7941325B2 (en) 2008-11-14 2011-05-10 Walgreen Co. System and method of using a non-retail central filling facility to process pharmacy product prescriptions in a pharmacy retail network
WO2010126797A1 (fr) 2009-04-29 2010-11-04 Onemednet Corporation Procédés, systèmes et dispositifs de gestion d'images et de dossiers médicaux
SI3351240T1 (sl) 2009-05-19 2019-08-30 Celgene Corporation Formulacije 4-amino-2-(2,6-dioksopiperidin-3-il)izoindolin-1,3-diona
WO2012019004A1 (fr) * 2010-08-04 2012-02-09 NextGen Management LLC Système et procédure de fourniture de prescription électronique
US20130151284A1 (en) * 2010-08-23 2013-06-13 Koninklijke Philips Electronics N.V. Assigning cases to case evaluators based on dynamic evaluator profiles
US10435192B2 (en) 2011-05-16 2019-10-08 Edge Medical Properties, Llc Multiple inspection system and method that inspects different medications
US10276054B2 (en) 2011-11-29 2019-04-30 Eresearchtechnology, Inc. Methods and systems for data analysis
NO2870072T3 (fr) 2012-07-05 2018-01-20
CN104619604B (zh) 2012-07-30 2017-04-05 P.C.O.A.设备有限公司 用于容纳和分配固体药用药丸的容器
JP6257953B2 (ja) * 2012-08-13 2018-01-10 東芝メディカルシステムズ株式会社 電子カルテ作成装置及び電子カルテ作成システム
EP2948204B1 (fr) 2013-01-28 2021-08-25 Smiths Medical ASD, Inc. Dispositifs et procédés de sécurité pharmaceutique
IL233295B (en) 2014-06-22 2019-11-28 Ilan Paz A control pill dispensing system
PL3182996T3 (pl) 2014-08-22 2023-04-17 Celgene Corporation Sposoby leczenia szpiczaka mnogiego związkami immunomodulującymi w kombinacji z przeciwciałami
IL238387B (en) 2015-04-20 2019-01-31 Paz Ilan Drug dispenser release mechanism
NZ741377A (en) 2015-10-09 2022-02-25 Deka Products Lp Fluid pumping and bioreactor system
US11501861B2 (en) * 2015-10-14 2022-11-15 David Alan Finkelstein System and method to access casualty health information in an emergency situation
EP3362030B1 (fr) 2015-10-15 2023-09-06 Dosentrx Ltd. Distributeurs de forme de dosage basés sur la reconnaissance d'image
US11458072B2 (en) 2015-11-02 2022-10-04 Dosentrx Ltd. Lockable advanceable oral dosage form dispenser containers
US10241703B2 (en) 2016-06-21 2019-03-26 International Business Machines Corporation Multivolume group management
US11299705B2 (en) 2016-11-07 2022-04-12 Deka Products Limited Partnership System and method for creating tissue
JP2018081527A (ja) * 2016-11-17 2018-05-24 きりんカルテシステム株式会社 電子カルテシステム
JP2018081528A (ja) * 2016-11-17 2018-05-24 きりんカルテシステム株式会社 電子カルテシステム
US10093647B1 (en) 2017-05-26 2018-10-09 Celgene Corporation Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof
US20180357387A1 (en) * 2017-06-07 2018-12-13 Tracelink, Inc. Dynamic full product lifecycle pharmaceutical data distribution
US10093648B1 (en) 2017-09-22 2018-10-09 Celgene Corporation Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate, compositions and methods of use thereof
US10093649B1 (en) 2017-09-22 2018-10-09 Celgene Corporation Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof
CN110752001A (zh) * 2019-05-05 2020-02-04 浙江亿诚智能科技有限公司 一种中药处方自动调剂取药方法及存储介质
US11886605B2 (en) * 2019-09-30 2024-01-30 Red Hat, Inc. Differentiated file permissions for container users
JP6741321B1 (ja) * 2019-10-30 2020-08-19 株式会社プレシジョン 薬剤例検索装置、薬剤例検索方法及び薬剤例検索プログラム
US20210304859A1 (en) * 2020-03-27 2021-09-30 Nariman Bharucha Cloud-based medical record management system with patient control

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023785A1 (de) * 1990-07-26 1992-01-30 Mueller & Sebastiani Elek Gmbh System zur speicherung, bereitstellung und aktualisierung von festen und/oder variablen patienten- und behandlungsdaten
US5299121A (en) * 1992-06-04 1994-03-29 Medscreen, Inc. Non-prescription drug medication screening system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US480899A (en) * 1892-08-16 Electrical measuring-instrument
US5072383A (en) * 1988-11-19 1991-12-10 Emtek Health Care Systems, Inc. Medical information system with automatic updating of task list in response to entering orders and charting interventions on associated forms
US5084828A (en) * 1989-09-29 1992-01-28 Healthtech Services Corp. Interactive medication delivery system
US5065315A (en) * 1989-10-24 1991-11-12 Garcia Angela M System and method for scheduling and reporting patient related services including prioritizing services
JPH04120651A (ja) * 1990-09-12 1992-04-21 Toshiba Corp 医療情報処理システム
JP3074535B2 (ja) * 1991-02-21 2000-08-07 株式会社日立製作所 医療情報提供システム
JP3100777B2 (ja) * 1992-08-31 2000-10-23 株式会社東芝 病院用診断支援装置
JPH0678885A (ja) * 1992-09-02 1994-03-22 Toshiba Corp 処方監査システム
JPH06187383A (ja) * 1992-12-21 1994-07-08 Hitachi Ltd 院外処方箋発行システム
JPH06231151A (ja) * 1993-01-29 1994-08-19 Sanyo Electric Co Ltd 医薬分業管理システム
JPH06259454A (ja) * 1993-03-03 1994-09-16 Toshiba Corp 医療総合情報システム

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023785A1 (de) * 1990-07-26 1992-01-30 Mueller & Sebastiani Elek Gmbh System zur speicherung, bereitstellung und aktualisierung von festen und/oder variablen patienten- und behandlungsdaten
US5299121A (en) * 1992-06-04 1994-03-29 Medscreen, Inc. Non-prescription drug medication screening system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9613790A1 *

Also Published As

Publication number Publication date
CA2201311A1 (fr) 1996-05-09
AU3972295A (en) 1996-05-23
BR9509357A (pt) 1997-12-30
EP0800680A1 (fr) 1997-10-15
WO1996013790A1 (fr) 1996-05-09
MX9702723A (es) 1998-04-30
JPH10508131A (ja) 1998-08-04

Similar Documents

Publication Publication Date Title
US5737539A (en) Prescription creation system
US5845255A (en) Prescription management system
US7072840B1 (en) Prescription management system
US7574370B2 (en) Prescription management system
US20100161353A1 (en) Prescription management system
EP0800680A1 (fr) Systeme de gestion des prescriptions
US6988075B1 (en) Patient-controlled medical information system and method
US9058410B2 (en) Integrated electronic patient health care data coordination system
Schiff et al. A prescription for enhancing electronic prescribing safety
US20020010595A1 (en) Web-based medication management system
US20030158755A1 (en) System and method for conducting drug use evaluation
US20090138281A1 (en) Patient-controlled medical information system and method
US11869642B2 (en) System and method to facilitate interoperability of health care modules
Coyle et al. Evolution of BCMA within the Department of Veterans Affairs
US20060010009A1 (en) Medication card and system
Goundrey-Smith Information Technology in Pharmacy: An Integrated Approach
JP2004118351A (ja) 医薬品検索情報提供システム
JP4583911B2 (ja) 薬品の安全性確認支援方法、安全性確認支援システム、およびプログラム
US20120245956A1 (en) Pharmacy-based data transfer methodology
US20240145049A1 (en) System and Method to Facilitate Interoperability of Health Care Modules
Dumitru The pharmacy informatics primer
US20210249111A1 (en) Medical platform unification tool
WO2001075770A2 (fr) Systeme de gestion de medication par le web
WO2002015095A1 (fr) Systeme de gestion d'ordonnances
Chu Electronic Prescription: Standards and Decision Support Issues,”

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970527

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IE IT LI SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IE IT LI SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990501